{
  "questions": [
    {
      "exact_answer": "yes",
      "id": "52cb9b9b03868f1b0600002d",
      "ideal_answer": "The study provides further evidence that the reported panel of diagnostic biomarkers can reliably achieve the noninvasive detection of bladder cancer with higher sensitivity than currently available urine based assays. CONCLUSIONS: Several gene-based urinary biomarkers have demonstrated promise in initial studies, which now need to be rigorously validated in the clinical setting for them to be translated into clinically useful tests in diagnosis, surveillance or risk-stratification of bladder cancer. Novel promising markers are in various stages of clinical testing, and a panel of biomarkers may serve in the future as a feasible alternative to urine cytology and cystoscopy for the screening, detection, and follow-up of non-muscle invasive bladder cancer. RESULTS: Seven of the 8 urine biomarkers were increased in subjects with bladder cancer relative to those without bladder cancer. We investigated the relationship between the expression of frequently deregulated microRNAs (miRNAs) as well as their target genes (ZEB1/ZEB2) and bladder cancer histopathological grade in an attempt to find a miRNA that might allow more reliable grading of PUTs. "
    },
    {
      "exact_answer": "yes",
      "id": "52ce531f03868f1b06000031",
      "ideal_answer": "Several immunodeficiencies have been treated successfully by stem cell-targeted, retroviral-mediated gene transfer with reconstitution of the immune system following infusion of the transduced cells. gef and apoptin genes were cloned into a doxycycline-regulated retrovirus-mediated gene expression system. containing a codon-optimized transgene (gp91(phox)) under the transcriptional control of a myeloid promoter for the gene therapy of the X-linked form of CGD (X-CGD). We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. We assessed lentiviral vectors (LVs) targeted to the EC surface marker CD105 for in vivo gene delivery. In this work we have developed and tested a self-inactivating (SIN) gammaretroviral vector (SINfes.gp91s). "
    },
    {
      "exact_answer": [
        [
          "Electroporation"
        ],
        [
          "Plasmids"
        ],
        [
          "DNA"
        ],
        [
          "RNA, Small Interfering"
        ],
        [
          "Cations"
        ],
        [
          "Transfection"
        ],
        [
          "Obstetric Delivery"
        ],
        [
          "Episomes"
        ],
        [
          "Lipids"
        ],
        [
          "Deoxyribonuclease I"
        ],
        [
          "MicroRNAs"
        ],
        [
          "Research Personnel"
        ],
        [
          "RNA, Messenger"
        ],
        [
          "Polymers"
        ],
        [
          "Viral Vector"
        ],
        [
          "Peptides"
        ],
        [
          "Liposomes"
        ],
        [
          "macropinocytosis"
        ],
        [
          "Nucleic Acids"
        ],
        [
          "Drug Formulation Process"
        ],
        [
          "Antibodies"
        ],
        [
          "Clathrin"
        ],
        [
          "degradation aspects"
        ],
        [
          "Test Method"
        ],
        [
          "RAPH1 gene"
        ],
        [
          "Proteins"
        ],
        [
          "Lipid A"
        ],
        [
          "TFRC gene"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "assay qualifier"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Phase"
        ],
        [
          "Formation"
        ],
        [
          "complex (molecular entity)"
        ],
        [
          "Morpholinos"
        ],
        [
          "Phaeodactylum tricornutum"
        ],
        [
          "Including (qualifier)"
        ],
        [
          "Oligodeoxyribonucleotides"
        ],
        [
          "enzymology"
        ],
        [
          "Carbamates"
        ],
        [
          "Assortment"
        ],
        [
          "deoxyribonuclease I activity"
        ],
        [
          "literary novel"
        ],
        [
          "Diatoms"
        ],
        [
          "Immobile"
        ],
        [
          "Genes, Jumping"
        ],
        [
          "Transgenes"
        ],
        [
          "Recombinants"
        ],
        [
          "size"
        ],
        [
          "Logical Condition"
        ],
        [
          "DNA Packaging"
        ],
        [
          "Treatment intent"
        ],
        [
          "Abnormally high"
        ],
        [
          "Abnormally low (qualifier value)"
        ],
        [
          "NPS gene"
        ],
        [
          "immunogenic"
        ],
        [
          "Extrinsic"
        ],
        [
          "Choose (action)"
        ],
        [
          "Pathogenicity Aspects"
        ],
        [
          "Scaffold"
        ],
        [
          "Series - set of composite instances"
        ],
        [
          "hydroxyl group"
        ],
        [
          "Exhibits as Topic"
        ],
        [
          "Links List"
        ],
        [
          "Limitation"
        ],
        [
          "combination of objects"
        ],
        [
          "Universal - VocabularyDomainQualifier"
        ],
        [
          "Cloning Vectors"
        ],
        [
          "Biologically active chemical"
        ],
        [
          "preference"
        ],
        [
          "Electric field"
        ],
        [
          "Lineage"
        ],
        [
          "Genetic Carriers"
        ],
        [
          "Reporting"
        ],
        [
          "Library Protocol"
        ],
        [
          "Accepted"
        ],
        [
          "cytotoxicity"
        ],
        [
          "Neutral Charge"
        ],
        [
          "Speed (motion)"
        ],
        [
          "Liquid substance"
        ],
        [
          "Introduction procedure"
        ],
        [
          "Data Transformation"
        ],
        [
          "Device Component System"
        ],
        [
          "STRENGTH (attribute)"
        ],
        [
          "Cell-Penetrating Peptides"
        ],
        [
          "Cell Nucleus"
        ],
        [
          "Protection"
        ],
        [
          "Characterization"
        ],
        [
          "Localized"
        ],
        [
          "Mixed (qualifier value)"
        ],
        [
          "Numerous"
        ],
        [
          "Biochemical Pathway"
        ],
        [
          "Uptake"
        ],
        [
          "Clinical Trial [Publication Type]"
        ],
        [
          "findings aspects"
        ],
        [
          "Efficiency"
        ],
        [
          "Biological Markers"
        ],
        [
          "Efficient"
        ],
        [
          "Injection of therapeutic agent"
        ],
        [
          "Nuclear"
        ]
      ],
      "id": "52d1389303868f1b06000032",
      "ideal_answer": "In addition to nuclei, investigators have variously injected peptides, antibodies, biologically active chemicals, lineage markers, mRNA, DNA, morpholinos, and enzymes. Complexes of Tf with cationic liposomes and nucleic acids, or liposomes with covalently attached Tf or anti-transferrin receptor antibodies have been used for the delivery of therapeutic genes, antisense oligodeoxynucleotides, and short interfering RNA. arious delivery carriers (cationic polymers, lipids, scaffolds, transposons, cell-penetrating peptides), cargos (episomal plasmids, minicircle DNA, small interfering RNAs, microRNAs, proteins, peptides), and method (electroporation) have been reported. Based on a universal electroporation protocol, the conditions for the introduction of exogenous DNA including electric field strength and plasmid form were optimized. Recombinant adeno-associated viral vectors (rAAV) have now been used in several clinical trials to treat a variety of diseases, and are currently the preferred choice of many investigators in the field, due to both their low pathogenicity and immunogenicity compared with other viral vectors, as well as localized long-term gene expression, despite their limitations of DNA size packaging and speed of expression. All lipoplex formulations exhibited plasmid DNA binding and a level of protection from DNase I degradation. "
    },
    {
      "exact_answer": [
        [
          "nuclease"
        ],
        [
          "Transcription Coactivator"
        ],
        [
          "Mediator brand of benfluorex hydrochloride"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Thalidomide"
        ],
        [
          "Edit"
        ],
        [
          "Genome - anatomical entity"
        ],
        [
          "DNA"
        ],
        [
          "AHR gene"
        ],
        [
          "Zinc Fingers"
        ],
        [
          "Engineer"
        ],
        [
          "Proteins"
        ],
        [
          "Target"
        ],
        [
          "RNA"
        ],
        [
          "Transgenes"
        ],
        [
          "Aryl Hydrocarbon Receptor Nuclear Translocator"
        ],
        [
          "Robust"
        ],
        [
          "endonuclease"
        ],
        [
          "AHR protein, human"
        ],
        [
          "Fused"
        ],
        [
          "Engineering"
        ],
        [
          "DNA Restriction Enzymes"
        ],
        [
          "Estrogen Receptors"
        ],
        [
          "TRANSCRIPTION FACTOR"
        ],
        [
          "Technology"
        ],
        [
          "Clustered Regularly Interspaced Short Palindromic Repeats"
        ],
        [
          "Site of"
        ],
        [
          "Free (available (qualifier))"
        ],
        [
          "Genome"
        ],
        [
          "Efficient"
        ],
        [
          "LRSAM1 gene"
        ],
        [
          "AAVS1 gene"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Cooley\u0027s anemia"
        ],
        [
          "Moldova"
        ],
        [
          "Negation"
        ],
        [
          "Sus scrofa"
        ],
        [
          "Hydrops Fetalis"
        ],
        [
          "Empowered"
        ],
        [
          "Incised wound"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Singular"
        ],
        [
          "Derivation"
        ],
        [
          "globin activity"
        ],
        [
          "Clinical Opiate Withdrawal Scale Questionnaire"
        ],
        [
          "Menopause"
        ],
        [
          "suggestion"
        ],
        [
          "Insert (object)"
        ],
        [
          "Induced Pluripotent Stem Cells"
        ],
        [
          "Encounter due to being a donor"
        ],
        [
          "Generations"
        ],
        [
          "Combine"
        ],
        [
          "Transcriptional Repression"
        ],
        [
          "Investigates"
        ],
        [
          "Biologic Development"
        ],
        [
          "Enabling"
        ],
        [
          "Universal - VocabularyDomainQualifier"
        ],
        [
          "Scientific Equipment"
        ],
        [
          "Reverse Genetics"
        ],
        [
          "Processed"
        ],
        [
          "Alleles"
        ],
        [
          "Cell Engineering"
        ],
        [
          "Alteration"
        ],
        [
          "Guide device"
        ],
        [
          "Correction Report"
        ],
        [
          "Correction (change)"
        ],
        [
          "Organism"
        ],
        [
          "Chromosomes, Human, Pair 19"
        ],
        [
          "Knock-out"
        ],
        [
          "Adaptive"
        ],
        [
          "DNA Integration"
        ],
        [
          "Integration (data processing)"
        ],
        [
          "Homologous Gene"
        ],
        [
          "Locus"
        ],
        [
          "Precise"
        ],
        [
          "Substrate Device Component"
        ],
        [
          "Device Component System"
        ],
        [
          "ResponseLevel - modification"
        ],
        [
          "Transcriptional Activation Domain"
        ],
        [
          "Example"
        ],
        [
          "Power (Psychology)"
        ],
        [
          "In situ"
        ],
        [
          "Numbers"
        ],
        [
          "Mutation"
        ],
        [
          "Gene Mutation"
        ],
        [
          "Cross Reactions"
        ],
        [
          "Breast Cancer Cell"
        ],
        [
          "Application procedure"
        ],
        [
          "Activation action"
        ],
        [
          "Immune system"
        ],
        [
          "Good"
        ],
        [
          "Evaluation"
        ],
        [
          "Direct type of relationship"
        ],
        [
          "Site"
        ],
        [
          "Specific site"
        ],
        [
          "DNA Sequence"
        ],
        [
          "Ability"
        ],
        [
          "Species"
        ],
        [
          "Review [Publication Type]"
        ],
        [
          "DNA Breaks, Double-Stranded"
        ]
      ],
      "id": "52d2818403868f1b06000033",
      "ideal_answer": "We used this opportunity to evaluate the effect of total donor homology on transcription activator-like effector nuclease (TALEN) mediated bi-allelic modification. Here, we describe a robust process combining efficient generation of integration-free β-Thal iPSCs from the cells of patients and transcription activator-like effector nuclease (TALEN)-based universal correction of HBB mutations in situ. We report here the correction of α-thalassemia major hydrops fetalis in transgene-free iPS cells using zinc finger-mediated insertion of a globin transgene in the AAVS1 site on human chromosome 19. In this study, we used zinc finger nuclease-mediated knockout of the aryl hydrocarbon receptor (AHR) or AHR nuclear translocator (ARNT) in MCF7 and AHR knockout in MDA-MB-231 human breast cancer cells to investigate cross talk among AHR, ARNT, and estrogen receptor α (ERα). Herein we describe our applications of site-specific nucleases, especially transcription activator-like effector nucleases, to engineer specific alterations in the genomes of pigs and cows. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Tal-effector nucleases (TALENs) are engineered proteins that can stimulate precise genome editing through specific DNA double-strand breaks. "
    },
    {
      "exact_answer": [
        [
          "NBEAL2 gene"
        ],
        [
          "Gray Platelet Syndrome"
        ],
        [
          "Mutation"
        ],
        [
          "NBEA gene"
        ],
        [
          "Encode (action)"
        ],
        [
          "Integer +2"
        ],
        [
          "Science of Etiology"
        ],
        [
          "Proteins"
        ],
        [
          "Beach (environment)"
        ],
        [
          "Exome"
        ],
        [
          "TRANSCRIPTION FACTOR"
        ],
        [
          "Sequence Determinations, DNA"
        ],
        [
          "GFI1B gene"
        ],
        [
          "Identified"
        ],
        [
          "Genes, vif"
        ],
        [
          "Dysmorphism"
        ],
        [
          "WD Repeat"
        ],
        [
          "Megakaryocytes"
        ],
        [
          "Mutation, Nonsense"
        ],
        [
          "THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED, ARG216GLN"
        ],
        [
          "X-linked inheritance"
        ],
        [
          "Autosomal dominant inheritance"
        ],
        [
          "Links List"
        ],
        [
          "combination of objects"
        ],
        [
          "Mutation Abnormality"
        ],
        [
          "Transcript"
        ],
        [
          "unrelated person"
        ],
        [
          "Blood Platelets"
        ],
        [
          "Entire upper arm"
        ],
        [
          "Etiology aspects"
        ],
        [
          "Sequencing - CodeSystem"
        ],
        [
          "Relationships"
        ],
        [
          "Dominant-Negative Mutation"
        ],
        [
          "Unique"
        ],
        [
          "Responsible to"
        ],
        [
          "RNA Sequence"
        ],
        [
          "Confirmed by"
        ],
        [
          "Individual"
        ],
        [
          "Loss"
        ],
        [
          "Genetic"
        ],
        [
          "Detected (finding)"
        ],
        [
          "Function"
        ]
      ],
      "id": "52d8494698d0239505000007",
      "ideal_answer": "We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome. Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. GPS has been linked to loss of function mutations in NEABL2 (neurobeachin-like 2). Genomic DNA sequencing confirmed mutations in NBEAL2 as the genetic cause of GPS. The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene. We sequenced the exomes of four unrelated individuals and identified NBEAL2 as the causative gene;. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. NBEAL2 is mutated in gray platelet syndrome. GFI1B, in addition to being causally related to the gray platelet syndrome,. A dominant-negative GFI1B mutation in the gray platelet syndrome. "
    },
    {
      "id": "52e204a998d0239505000012",
      "ideal_answer": "We discuss the general implications of molecular epigenetics with special emphasis on drug abuse, bar-codes, pyknons, and miRNAs for translational and clinical research. Allele-specific sequence variations link disease-associated SNPs to distinct sets of pyknons and microRNAs, suggesting that increased susceptibility to multiple common human disorders is associated with global alterations of genome-wide regulatory templates affecting the biogenesis and functions of non-coding RNAs. A. thaliana pyknons exhibit features similar to human pyknons, including being distinct sequence patterns, having multiple instances in genes and having remarkable similarity to small RNA sequences with roles in gene silencing. We demonstrate that genome-unique SNP-coding sequences associated with multiple common human disorders appear assembled from series of ubiquitous short octamer sequences shared by 5\u0027-UTR pyknons and microRNAs. Because the A. thaliana and human genomes have approximately the same number of genes but drastically different amounts of non-coding DNA, these data reveal that pyknons represent a biologically important link between coding and non-coding DNA. Because of the association of pyknons with siRNAs and localization to silenced regions of heterochromatin, we postulate that RNA-mediated gene silencing leads to the accumulation of gene sequences in non-coding DNA regions. "
    },
    {
      "exact_answer": [
        [
          "Genus Tuber (fungus)"
        ],
        [
          "Pulmonary lymphangioleiomyomatosis"
        ],
        [
          "Lesion"
        ],
        [
          "Subependymal Giant Cell Astrocytoma"
        ],
        [
          "Hepatic Angiomyolipoma"
        ],
        [
          "Multiple bilateral renal angiomyolipoma"
        ],
        [
          "Angiomyolipoma of kidney"
        ],
        [
          "coexistent conditions"
        ],
        [
          "Tuberous Sclerosis"
        ],
        [
          "Autistic behaviors"
        ],
        [
          "shared attribute"
        ],
        [
          "Small"
        ],
        [
          "Biologic Development"
        ],
        [
          "Aspects of mortality statistics"
        ],
        [
          "Cyst"
        ],
        [
          "Mental Retardation"
        ],
        [
          "Periodic"
        ],
        [
          "Seizures"
        ],
        [
          "Science of Etiology"
        ],
        [
          "Medical Surveillance"
        ],
        [
          "Symptom severe"
        ],
        [
          "Complicated"
        ],
        [
          "Cohort"
        ],
        [
          "Bilateral"
        ],
        [
          "Benign"
        ],
        [
          "TSC1-TSC2 complex location"
        ],
        [
          "Presentation"
        ],
        [
          "Numerous"
        ],
        [
          "Case unit dose"
        ],
        [
          "Morbidity - disease rate"
        ],
        [
          "Magnetic Resonance Imaging"
        ],
        [
          "Medium"
        ],
        [
          "Now (temporal qualifier)"
        ],
        [
          "Imaging Techniques"
        ],
        [
          "Standard of Care"
        ],
        [
          "size"
        ],
        [
          "year"
        ],
        [
          "Large"
        ],
        [
          "Identified"
        ],
        [
          "1+ Score, WHO"
        ],
        [
          "Some (qualifier value)"
        ],
        [
          "Time"
        ],
        [
          "Clinical"
        ]
      ],
      "id": "52f77f042059c6d71c000029",
      "ideal_answer": "Most cases of tuberous sclerosis complex are complicated with bilateral multiple renal angiomyolipoma. Although large tubers are less common than small to medium-sized ones, they are much more likely to be accompanied by severe clinical symptoms (seizures, mental retardation and autistic behaviour), even when the smaller tubers are quite numerous. Hepatic angiomyolipomas (AML), cysts, and other benign lesions were identified in 30% of the cohort, and some lesions grew significantly over time. Pulmonary lymphangioleiomyomatosis and bilateral renal angiomyolipomas are some presentations of tuberous sclerosis and the coexistence of both conditions may cause devastating morbidity and mortality. Periodic imaging surveillance for development of subependymal giant cell astrocytoma (SEGA), preferably by magnetic resonance imaging (MRI) every 1-3 years, is now standard of care. "
    },
    {
      "exact_answer": [
        [
          "RNMT gene"
        ],
        [
          "mRNA guanylyltransferase"
        ],
        [
          "RNGTT gene"
        ],
        [
          "Polymerase"
        ],
        [
          "RNA Polymerase II"
        ],
        [
          "Integer +5"
        ],
        [
          "Phosphoric Monoester Hydrolases"
        ],
        [
          "Catalysis"
        ],
        [
          "Cap formation"
        ],
        [
          "Transcript"
        ],
        [
          "Mammals"
        ],
        [
          "Initiation"
        ],
        [
          "RNA, Messenger"
        ],
        [
          "Transcription, Genetic"
        ],
        [
          "DNA-Directed RNA Polymerase"
        ],
        [
          "phosphoric monoester hydrolase activity"
        ],
        [
          "enzymology"
        ],
        [
          "Syringe Caps"
        ],
        [
          "Translating"
        ],
        [
          "Add - instruction imperative"
        ],
        [
          "Analog"
        ],
        [
          "Nucleotides"
        ],
        [
          "Sequential"
        ],
        [
          "Early Gene Transcription"
        ],
        [
          "Occur (action)"
        ],
        [
          "Clinical action"
        ],
        [
          "Early stage"
        ],
        [
          "Stage"
        ],
        [
          "In Vitro [Publication Type]"
        ],
        [
          "8-methylguanosine"
        ]
      ],
      "id": "52f77f4d2059c6d71c00002a",
      "ideal_answer": "Synthesis of the methyl cap initiates with the addition of 7-methylguanosine to the initiating nucleotide of RNA pol II (polymerase II) transcripts, which occurs predominantly during transcription and in mammals is catalysed by RNGTT (RNA guanylyltransferase and 5\u0027 phosphatase) and RNMT (RNA guanine-7 methyltransferase). In mammals, cap synthesis is catalysed by the sequential action of RNGTT (RNA guanylyltransferase and 5\u0027-phosphatase) and RNMT (RNA guanine-7 methyltransferase), enzymes recruited to RNA pol II (polymerase II) during the early stages of transcription. The cap analogues are incorporated by RNA polymerase into mRNA transcripts that are efficiently translated in vitro. "
    },
    {
      "exact_answer": "yes",
      "id": "52f77f892059c6d71c00002c",
      "ideal_answer": "As a first step to elucidate the mechanism(s) by which ribosomes bypass leaky stop codons in vivo, we have devised a system in which readthrough is coupled to the transient expression of beta-glucuronidase (GUS) in tobacco protoplasts. Recent studies on translation termination in the yeast Saccharomyces cerevisiae have not only enabled the identification of the key components of the termination machinery, but have also revealed several regulatory mechanisms that might enable the controlled synthesis of C-terminally extended polypeptides via stop-codon readthrough. The effects of all possible single-base mutations in the codons flanking the stop indicated that 3\u0027 contexts of the form CAR-YYA confer leakiness and that the 3\u0027 context permits read through of UAA and UGA stop codons as well as UAG. Expression of retroviral replication enzymes (Pol) requires a controlled translational recoding event to bypass the stop codon at the end of gag. This recoding event occurs either by direct suppression of termination via the insertion of an amino acid at the stop codon (readthrough) or by alteration of the mRNA reading frame (frameshift). "
    },
    {
      "exact_answer": [
        [
          "Heterochromatin"
        ],
        [
          "Lysine"
        ],
        [
          "Staphylococcal Protein A"
        ],
        [
          "Massive"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Histone H3"
        ],
        [
          "KRT9 gene"
        ],
        [
          "histone methyltransferase"
        ],
        [
          "SUV39H1 gene"
        ],
        [
          "histone modification"
        ],
        [
          "histone methylation"
        ],
        [
          "Histones"
        ],
        [
          "Methyltransferase"
        ],
        [
          "ResponseLevel - modification"
        ],
        [
          "Associated with"
        ],
        [
          "chromocenter"
        ],
        [
          "SUV39H1 wt Allele"
        ],
        [
          "methylate"
        ],
        [
          "heterochromatin-specific nonhistone chromosomal protein HP-1"
        ],
        [
          "Distributing"
        ],
        [
          "Levels (qualifier value)"
        ],
        [
          "SIRT1 gene"
        ],
        [
          "Enrich"
        ],
        [
          "Centromere"
        ],
        [
          "Phylogeny"
        ],
        [
          "Abnormally high"
        ],
        [
          "Arabidopsis"
        ],
        [
          "Protein methylation"
        ],
        [
          "allowing"
        ],
        [
          "classical example"
        ],
        [
          "Y Chromosome"
        ],
        [
          "Communication"
        ],
        [
          "consider"
        ],
        [
          "Human Study Subject"
        ],
        [
          "localization"
        ],
        [
          "Cell Nucleus"
        ],
        [
          "Contain (action)"
        ],
        [
          "Marked"
        ],
        [
          "Biological Markers"
        ],
        [
          "Identification (Psychology)"
        ],
        [
          "Strong"
        ],
        [
          "Occur (action)"
        ],
        [
          "Affect (mental function)"
        ],
        [
          "Male Gender, Self Report"
        ],
        [
          "Binding Sites"
        ],
        [
          "Good"
        ],
        [
          "Loss"
        ],
        [
          "Dependent - ability"
        ],
        [
          "Mechanism (attribute)"
        ],
        [
          "Molecular"
        ],
        [
          "Activity level"
        ],
        [
          "Including (qualifier)"
        ],
        [
          "Increase"
        ]
      ],
      "id": "52fe4ad52059c6d71c000077",
      "ideal_answer": "is uniformly enriched in histone methylation marks usually found in constitutive heterochromatin, such as H4K20me3, H3K9me3, and H3K79me3. Classical histone modifications associated with heterochromatin, including H3K9me2, H3K27me1 and H3K27me2. histone Lys methyltransferase has allowed the identification of a molecular mechanism in which the specific methylation of histone H3 at Lys9 generates a binding site for heterochromatin-associated proteins. strong methylation at H3 lysine 9 occurred preferentially in heterochromatic chromocenters of Arabidopsis nuclei. heterochromatin contains histones that are generally hypoacetylated and methylated by Suv39h methyltransferases at lysine 9 of histone H3 (H3-K9). constitutive heterochromatin of the centromere is marked by high levels of trimethylated histone H3 lysine 9 (H3K9). Loss of SIRT1 greatly affects SUV39H1-dependent H3K9me3 and impairs localization of heterochromatin protein 1. H3K9me3, the subject of this communication, which is a modification that has traditionally been considered a mark of constitutive heterochromatin. the phylogenetic distribution of H3K9me as heterochromatin-specific histone modification. elevated levels of SUV39H1 activity resulting in increased levels of the H3K9me3 modification. Trimethylated H3(K9) marks pericentromeric constitutive heterochromatin and the male Y chromosome. H3S10P is a good marker of pericentromeric heterochromatin. H3K9me3 marked pericentromeric heterochromatin. "
    },
    {
      "exact_answer": [
        [
          "Histones"
        ],
        [
          "Proteins"
        ],
        [
          "HU Protein"
        ],
        [
          "Prokaryote"
        ],
        [
          "Annexin A2"
        ],
        [
          "nucleoid"
        ],
        [
          "Protons"
        ],
        [
          "Abnormally high"
        ],
        [
          "Architecture as Topic"
        ],
        [
          "Abundance"
        ],
        [
          "DNA Replication"
        ],
        [
          "Mental concentration"
        ],
        [
          "Structure"
        ],
        [
          "Function"
        ]
      ],
      "id": "52fe54252059c6d71c000079",
      "ideal_answer": "In prokaryotes, IHF and HU are key architectural proteins present at high concentrations. the ubiquitous HU proteins, serve histone-like functions in prokaryotes. most abundant histone-like protein HU i. that Histone-like Nucleoid Structuring (H-NS) protein. histone-like protein HU. histone-like protein H-NS. histone-like protein HU in DNA replication. "
    },
    {
      "exact_answer": [
        [
          "Replication Origin"
        ],
        [
          "Archaea"
        ],
        [
          "Sulfolobus"
        ],
        [
          "Numerous"
        ],
        [
          "Replicate"
        ]
      ],
      "id": "52fe58f82059c6d71c00007a",
      "ideal_answer": "Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins. The strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication. multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait to the archaea. The analysis of the y component of the Z curve, i.e., MK disparity curve, suggests the presence of another replication origin corresponding to one of the peaks in the MK disparity curve at around 1,388 kb of the genom. In addition, the potential multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve method. Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal genome. We employed Z-curve analysis to identify one replication origin in the Methanocaldococcus jannaschii genome, two replication origins in the Halobacterium species NRC-1 genome and one replication origin in the Methanosarcina mazei genome. Based on the above analysis, a model of replication of Halobacterium NRC-1 with two replication origins and two termini has been proposed. "
    },
    {
      "exact_answer": [
        [
          "Cathepsin G"
        ],
        [
          "Alteplase"
        ],
        [
          "Dinucleoside Phosphates"
        ],
        [
          "Representation (action)"
        ],
        [
          "Dinucleotide Repeats"
        ]
      ],
      "id": "52ffbddf2059c6d71c00007d",
      "ideal_answer": "espite being generally under-represented in the genome, CpG sequences represent a disproportionately high fraction of sites involved in mutational events leading to human genetic disease. Dinucleotide repeats are found in 4,018 nonredundant sequences, mainly in the 5\u0027-untranslated region of the gene, with a bias toward one repeat type (containing AG, 88%) and against another (repeats containing CG, 0.1%). Strong CG and TA dinucleotide underrepresentation is observed at all codon positions as well as in non-coding regions. pG and TpA dinucleotides are underrepresented in the human genome. "
    },
    {
      "exact_answer": "yes",
      "id": "530cf4fe960c95ad0c000003",
      "ideal_answer": "The arrhythmias may cause syncope or degenerate into cardiac arrest and sudden death which usually occurs during childhood. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a cardiac channelopathy characterized by altered intracellular calcium handling resulting in ventricular arrhythmias and high risk of cardiac sudden death in young cases with normal structural hearts. The inherited arrhythmogenic diseases associated with the transmembranous ionic channels, anchoring proteins or intracellular calcium regulating proteins are thought to be responsible for sudden cardiac death in infants, children, and young adults who have structurally normal hearts. Here we refine our approach, and apply it to novel variants found in 2266 patients across two large cohorts with inherited sudden death syndromes, namely catecholaminergic polymorphic ventricular tachycardia (CPVT) or Brugada syndrome (BrS). Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a devastating inherited disorder characterized by episodic syncope and/or sudden cardiac arrest during exercise or acute emotion in individuals without structural cardiac abnormalities. Calsequestrin-associated catecholaminergic polymorphic ventricular tachycardia (CPVT2) can cause sudden death in young individuals in response to stress. "
    },
    {
      "exact_answer": [
        [
          "CALCIUM SUPPLEMENTS"
        ],
        [
          "Silo (dataset)"
        ],
        [
          "Struvite calculus"
        ],
        [
          "Urate calculus"
        ],
        [
          "Calculi"
        ]
      ],
      "id": "5311bcc2e3eabad021000005",
      "ideal_answer": "calcium oxalate remains the dominant type accounting for 64% of stones in our dataset,. Uric acid stones contributed 16% of contemporary stone compositions,. Struvite stones showed a decreasing trend from 14% in the 1970s, to 12% in the 1980s and 7% in the current data. . Given recent concerns that calcium supplements may raise risk for cardiovascular disease and kidney stones,. "
    },
    {
      "exact_answer": [
        [
          "Fluorides"
        ],
        [
          "flutemetamol"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Amyvid"
        ],
        [
          "Pet Animal"
        ],
        [
          "FLORBETAPIR F-18"
        ],
        [
          "Alzheimer\u0027s Disease Pathway KEGG"
        ],
        [
          "Radiopharmaceuticals"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Senile Plaques"
        ],
        [
          "Serum amyloid A protein"
        ],
        [
          "Amyloid deposition"
        ],
        [
          "Image"
        ],
        [
          "Ligands"
        ],
        [
          "Support Vector Machines"
        ],
        [
          "SUCLA2 gene"
        ],
        [
          "Fluorodeoxyglucose F18"
        ],
        [
          "Subject - topic"
        ],
        [
          "Apolipoprotein E4"
        ],
        [
          "In Vivo"
        ],
        [
          "radiotracer"
        ],
        [
          "Imaging Techniques"
        ],
        [
          "Magnetic Resonance Imaging"
        ],
        [
          "Deoxyglucose"
        ],
        [
          "Analysis of substances"
        ],
        [
          "Cerebral cortex"
        ],
        [
          "P prime"
        ],
        [
          "Assignment - action"
        ],
        [
          "Visual"
        ],
        [
          "Classification"
        ],
        [
          "Histologic"
        ],
        [
          "APP wt Allele"
        ],
        [
          "Abnormally high"
        ],
        [
          "Beta Amyloid Measurement"
        ],
        [
          "Reading (activity)"
        ],
        [
          "Presenile dementia"
        ],
        [
          "Geographic Locations"
        ],
        [
          "Plaque, Amyloid"
        ],
        [
          "Numerous"
        ],
        [
          "Histopathology"
        ],
        [
          "Specificity"
        ],
        [
          "findings aspects"
        ],
        [
          "Structure"
        ],
        [
          "Diagnosis Study"
        ],
        [
          "4-iodobenzenesulfonamide"
        ],
        [
          "Providing (action)"
        ],
        [
          "Mild cognitive disorder"
        ],
        [
          "suggestion"
        ],
        [
          "Ability"
        ],
        [
          "Scientific Study"
        ],
        [
          "Replicate"
        ],
        [
          "Tracer"
        ],
        [
          "regional"
        ],
        [
          "Labeled (qualifier)"
        ],
        [
          "Scanning"
        ],
        [
          "Clinical"
        ],
        [
          "Largest"
        ],
        [
          "Correlation"
        ],
        [
          "Percent normal"
        ],
        [
          "Shortened"
        ],
        [
          "Elderly (population group)"
        ],
        [
          "Positron-Emission Tomography"
        ],
        [
          "Clinical Trial [Publication Type]"
        ],
        [
          "Population Mean"
        ],
        [
          "Brain"
        ],
        [
          "Clusterin"
        ],
        [
          "Binding (Molecular Function)"
        ],
        [
          "density"
        ],
        [
          "Presence"
        ],
        [
          "fluorodeoxyglucose"
        ],
        [
          "Techniques"
        ],
        [
          "Study Subject"
        ],
        [
          "Voxel"
        ],
        [
          "Statistical sensitivity"
        ],
        [
          "BAY94 9172"
        ],
        [
          "Transportation Services - Train"
        ],
        [
          "Compound (substance)"
        ],
        [
          "Biological Markers"
        ],
        [
          "Onset of (contextual qualifier)"
        ],
        [
          "Apolipoprotein E"
        ],
        [
          "Associated with"
        ],
        [
          "Triglycerides"
        ],
        [
          "LDL Cholesterol Lipoproteins"
        ],
        [
          "Gray matter"
        ],
        [
          "1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride"
        ],
        [
          "millicurie"
        ],
        [
          "Decay (action)"
        ],
        [
          "Preposition For"
        ],
        [
          "dense plaque"
        ],
        [
          "florbetapir"
        ],
        [
          "Numerical value"
        ],
        [
          "High Density Lipoprotein Cholesterol"
        ],
        [
          "utilization qualifier"
        ],
        [
          "Biospecimen"
        ],
        [
          "allowing"
        ],
        [
          "Arabic numeral 68"
        ],
        [
          "Arabic numeral 55"
        ],
        [
          "Internal-External Locus of Control Scale"
        ],
        [
          "Positrons"
        ],
        [
          "Gram per Deciliter"
        ]
      ],
      "id": "5311bf53e3eabad021000006",
      "ideal_answer": "g biomarkers of Alzheimer\u0027s disease include amyloid deposition [imaged with [(11)C]Pittsburgh compound B (PiB) PET], altered glucose metabolism (imaged with [(18)F]fluro-deoxyglucose PET), and structural atrophy (imaged by MRI). We evaluated whether a supervised machine learning technique, support vector machines (SVM), can replicate the assignments made by visual readers blind to the clinical diagnosis, which image components have highest diagnostic value according to SVM and how (18)F-flutemetamol-based classification using SVM relates to structural MRI-based classification using SVM within the same subjects. This pooled analysis of four studies determined the level of association between uptake of the fibrillar amyloid β positron emission tomography (PET) imaging agent [(18)F]flutemetamol (Pittsburgh Compound B analog with a 5.5 times longer half-life to enable it to be used in the clinical setting). Among the new widely available fluorine 18 ((18)F)-labeled Aβ ligands, florbetapir F 18 ((18))F-AV-45; Amyvid™) showed clear qualitative and quantitative correlations between in vivo PET imaging and postmortem histopathologic analysis of Aβ. "
    },
    {
      "exact_answer": "yes",
      "id": "5311cdcce3eabad021000007",
      "ideal_answer": "Since current manual FISH signal analysis is low-efficient and inconsistent, which limits its clinical utility, developing automated FISH image scanning systems and computer-aided detection (CAD) schemes has been attracting research interests. When compared with other pixel-wise M-FISH image classifiers such as fuzzy c-means (FCM) clustering algorithms and adaptive fuzzy c-means (AFCM) clustering algorithms that we proposed earlier the current method gave the lowest classification error. The simultaneous detection of protein expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other which often results in suboptimal staining.Therefore, we developed a novel automated algorithm based on relocation which allows subsequent detection of protein content and gene copy number changes within the same cell. "
    },
    {
      "exact_answer": [
        [
          "Greek letter tau"
        ],
        [
          "Alzheimer\u0027s Disease Pathway KEGG"
        ],
        [
          "Circumferential Supracrestal Fiberotomy"
        ],
        [
          "Presenile dementia"
        ],
        [
          "Cerebrospinal Fluid"
        ],
        [
          "Biological Markers"
        ],
        [
          "Mild cognitive disorder"
        ],
        [
          "Serum amyloid A protein"
        ],
        [
          "Tumor stage"
        ],
        [
          "Volumetric"
        ],
        [
          "chemokine"
        ],
        [
          "Before values"
        ],
        [
          "Air Pollution"
        ],
        [
          "cytokine"
        ],
        [
          "Patients"
        ],
        [
          "SUCLA2 gene"
        ],
        [
          "Detected (finding)"
        ],
        [
          "Response process"
        ],
        [
          "Negation"
        ],
        [
          "Total"
        ],
        [
          "Qualification"
        ],
        [
          "Conversions"
        ],
        [
          "Disease"
        ],
        [
          "fluorodeoxyglucose positron emission tomography"
        ],
        [
          "Bad"
        ],
        [
          "suggestion"
        ],
        [
          "APP wt Allele"
        ],
        [
          "Abnormally low (qualifier value)"
        ],
        [
          "P prime"
        ],
        [
          "Gray matter"
        ],
        [
          "Gray color"
        ],
        [
          "Investigates"
        ],
        [
          "combination of objects"
        ],
        [
          "Offspring"
        ],
        [
          "Specimen Type - Serum"
        ],
        [
          "Beta Amyloid Measurement"
        ],
        [
          "Progressive Neoplastic Disease"
        ],
        [
          "False"
        ],
        [
          "Hippocampus (Brain)"
        ],
        [
          "Modulated"
        ],
        [
          "White color"
        ],
        [
          "Inclusion"
        ],
        [
          "Alzheimer\u0027s Disease"
        ],
        [
          "allowing"
        ],
        [
          "White matter"
        ],
        [
          "Risks and Benefits"
        ],
        [
          "Entire brain"
        ],
        [
          "predictive"
        ],
        [
          "Fragment of (qualifier value)"
        ],
        [
          "Possibly Related to Intervention"
        ],
        [
          "Elderly (population group)"
        ],
        [
          "Pathological aspects"
        ],
        [
          "Mental concentration"
        ],
        [
          "Positive Finding"
        ],
        [
          "Compound (substance)"
        ],
        [
          "criteria"
        ],
        [
          "stages of change"
        ],
        [
          "research clinical testing"
        ],
        [
          "Measures"
        ],
        [
          "Clinical Trials"
        ],
        [
          "Volume"
        ],
        [
          "Not Defined"
        ],
        [
          "Well defined"
        ],
        [
          "Ratio"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Imaging Techniques"
        ],
        [
          "Good"
        ],
        [
          "Sensitive"
        ],
        [
          "Better"
        ],
        [
          "Structure"
        ],
        [
          "complex (molecular entity)"
        ],
        [
          "Reduced"
        ],
        [
          "Early"
        ],
        [
          "Health"
        ]
      ],
      "id": "5311d130e3eabad021000009",
      "ideal_answer": "Alzheimer\u0027s disease (AD) patients have reduced amyloid (Aβ 1-42) and elevated total tau (t-tau) and phosphorylated tau (p-tau 181p) in the cerebro-spinal fluid (CSF), suggesting that these same measures could be used to detect early AD pathology in healthy elderly (CN) and mild cognitive impairment (MCI). investigate the dynamics of four of the most validated biomarkers for Alzheimer\u0027s disease (AD), cerebro-spinal fluid (CSF) Abeta 1-42, tau, hippocampal volume, and FDG-PET, in patients at different stage of AD. although high CSF tau and low CSF Aβ42 are predictive of Alzheimer\u0027s disease, the criterion \"positive CSF tau/Aβ42 ratio\" is not well defined. The qualification of biomarkers in the pre-dementia stage of Alzheimer\u0027s disease will allow better inclusion criteria of patients in pre-dementia trials in which the benefit/risk is higher for treatment with these novel compounds. A complex modulation of serum cytokines and chemokines influences children\u0027s brain structural and gray/white matter volumetric responses to air pollution. Alzheimer\u0027s disease (AD) may be facilitated by cerebro-spinal fluid (CSF) biomarkers in combination with imaging and clinical assessments. "
    },
    {
      "exact_answer": [
        [
          "COSTELLO SYNDROME (allelic variant)"
        ],
        [
          "Growth Hormone"
        ],
        [
          "Hydrocortisone"
        ],
        [
          "TRICHOHEPATOENTERIC SYNDROME"
        ],
        [
          "Somatotropin deficiency"
        ]
      ],
      "id": "53130a77e3eabad02100000f",
      "ideal_answer": "Progressively worsening hypertrophic cardiomyopathy in a child with newly diagnosed Costello syndrome while receiving growth hormone therapy. This report highlights two important concepts: the association of genetic syndromes with hypertrophic cardiomyopathy and the possibility of worsening severity of hypertrophic cardiomyopathy linked to growth hormone therapy. Thus, although osteofibrous dysplasia in Costello syndrome has not been reported before, growth hormone therapy should be used under close supervision in children with this syndrome. We review the pathophysiology of Costello syndrome and highlight the recent recommendations of tumor screening and cardiac surveillance in this population, of particular relevance to those receiving GH therapy. Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients. We report on three patients with Costello syndrome and isolated growth hormone (GH) deficiency treated with biosynthetic GH. Furthermore, we observed that RasGRF1 becomes phosphorylated in ARMS after stimulation by several pro-metastatic factors, such as SDF-1 and HGF/SF, as well as after exposure to growth-promoting Igf-2 and insulin. "
    },
    {
      "exact_answer": [
        [
          "XK gene"
        ],
        [
          "Mutation"
        ],
        [
          "Blood group deletion syndrome"
        ],
        [
          "Etiology aspects"
        ],
        [
          "Exons"
        ]
      ],
      "id": "531464a6e3eabad021000014",
      "ideal_answer": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles. The detailed characterization at the molecular biology level of this novel XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype correlation in the McLeod syndrome. Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features. With the discovery of their molecular bases, mutations of the X-linked gene XK and autosomal recessive mutations of the gene coding for chorein, respectively, the two phenotypes can now be differentiated and extend the diagnostic spectrum in patients presenting with chorea. Despite documented McLeod phenotype on RBCs, and identified mutations of XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. "
    },
    {
      "exact_answer": [
        [
          "Favism"
        ],
        [
          "Enzymopathy"
        ],
        [
          "Icterus"
        ],
        [
          "Vicia faba"
        ],
        [
          "Hematuria"
        ],
        [
          "shared attribute"
        ],
        [
          "Abnormally high"
        ],
        [
          "Encounter"
        ],
        [
          "Anemia, Hemolytic"
        ],
        [
          "Maxillary right canine distal prosthesis"
        ],
        [
          "Manifestation of"
        ],
        [
          "Endemic Diseases"
        ],
        [
          "Symptoms aspect"
        ],
        [
          "Clinical"
        ],
        [
          "Entire kidney"
        ],
        [
          "Red blood cells, blood product"
        ],
        [
          "deficiency aspects"
        ],
        [
          "Kidney"
        ],
        [
          "Affect (mental function)"
        ],
        [
          "Evaluation"
        ],
        [
          "Area"
        ],
        [
          "Liver"
        ],
        [
          "Liver function"
        ],
        [
          "Primary"
        ],
        [
          "Rate"
        ],
        [
          "Patients"
        ],
        [
          "Long-term"
        ]
      ],
      "id": "5314b20bdae131f847000005",
      "ideal_answer": "Thus we evaluate kidney and liver function of favism patients in an endemic area of the disease with a high rate of fava beans cultivation. The clinical symptoms of favism are jaundice, hematuria and haemolytic anaemia that seem to affect liver and kidney in long term. 6PD deficiency is the most common enzymopathy of red blood cells. The principal clinical manifestation encountered was favism. "
    },
    {
      "exact_answer": "yes",
      "id": "5318352fb166e2b806000011",
      "ideal_answer": "Recent work demonstrates that a phosphorylated form of the mitochondrial fusion protein Mitofusin 2 serves as a receptor for Parkin translocation to damaged mitochondria. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria. "
    },
    {
      "exact_answer": [
        [
          "Svalbard and Jan Mayen"
        ],
        [
          "Onset of illness"
        ],
        [
          "Syndrome"
        ],
        [
          "Autoimmune reaction"
        ],
        [
          "Xerostomia"
        ]
      ],
      "id": "53189b05b166e2b80600001e",
      "ideal_answer": "Sjögren\u0027s syndrome (SjS) is a human autoimmune disease characterized by the loss of exocrine function as a result of a chronic immune attack directed primarily against the salivary and lacrimal glands leading to xerostomia (dry mouth) and xerophthalmia (dry eyes). Sjögren\u0027s syndrome (SjS) is a systemic autoimmune disease in which an immunological attack against the salivary and lacrimal glands results, respectively, in severe dry mouth and dry eye diseases. Sjögren\u0027s syndrome (SjS) is a human autoimmune disease characterized by exocrine dysfunction resulting from chronic autoimmune attack primarily against the lacrimal and/or salivary glands. In Sjögren\u0027s syndrome the autoimmune response is directed against the exocrine glands, which, as histopathological hallmark of the disease, display persistent and progressive focal mononuclear cell infiltrates. NOD mice manifest many features of autoimmune exocrinopathy (Sjögren\u0027s syndrome), a disease generally characterized by a chronic, progressive immunological attack against the exocrine tissues of the salivary and lacrimal glands. The purpose of this qualitative research was to explore the lived experiences of women with Sjogren\u0027s Syndrome (SS), a chronic autoimmune syndrome in which invading lymphocytes attack moisture-producing glands of the body. "
    },
    {
      "exact_answer": "yes",
      "id": "5319abc9b166e2b80600002d",
      "ideal_answer": "It has been reported as an important inducer of cancer cell migration and invasion, with underlying molecular mechanisms involving the signalling mediated by its juxtamembrane domain, the secretion of matrix metalloproteases to the extracellular media, and the cleavage of a P-cadherin soluble form with pro-invasive activity. These data suggest that P-Rex1 has an influence on physiological migratory processes, such as invasion of cancer cells, both through effects upon classical Rac1-driven motility and a novel association with RTK signalling complexes. We also find that Rac1 GTPase mediates tight binding of prostate cancer cells to bone marrow endothelial cells and promotes retraction of endothelial cells required for tumor cell diapedesis. These results demonstrated for the first time that the interaction of CCR1 with CCL5 caused by increased expression of CCR1 promotes invasion of PC3PR cells by increasing secretion of MMPs 2 and 9 and by activating ERK and Rac signaling. Activated PAR1 induced RhoA and Rac1 phosphorylation, and subsequent overexpression of myosin IIA and filamin B which are stress fiber components that were identified by PMF analysis of peptide mass data obtained by MALDI-TOF/MS measurement. "
    },
    {
      "exact_answer": [
        [
          "CDH17 gene"
        ],
        [
          "Mediator brand of benfluorex hydrochloride"
        ],
        [
          "SNAI2 gene"
        ],
        [
          "Promoter"
        ],
        [
          "Repression, Psychology"
        ],
        [
          "TCF4 gene"
        ],
        [
          "ZEB1 wt Allele"
        ],
        [
          "SNAI1 gene"
        ],
        [
          "Fibrinogen"
        ],
        [
          "Expression procedure"
        ],
        [
          "Induce (action)"
        ],
        [
          "CDH1 gene"
        ],
        [
          "DNA Methylation"
        ],
        [
          "SUV39H1 gene"
        ],
        [
          "SNAI2 wt Allele"
        ],
        [
          "EHMT2 gene"
        ],
        [
          "Malignant neoplasm of breast"
        ],
        [
          "ZEB2 gene"
        ],
        [
          "epithelial to mesenchymal transition"
        ],
        [
          "Transcription Repressor/Corepressor"
        ],
        [
          "ZEB1 gene"
        ],
        [
          "Thrombin"
        ],
        [
          "Methyltransferase"
        ],
        [
          "Regulator"
        ],
        [
          "Fibronectins"
        ],
        [
          "TRANSCRIPTION FACTOR"
        ],
        [
          "Lysine"
        ],
        [
          "Cultured Cell Line"
        ],
        [
          "Transcriptional Repression"
        ],
        [
          "Identification (Psychology)"
        ],
        [
          "Snails"
        ],
        [
          "DNA Modification Methylases"
        ],
        [
          "ETV5 gene"
        ],
        [
          "Histone-Lysine N-Methyltransferase SUV39H1"
        ],
        [
          "Cadherins"
        ],
        [
          "Recombinant Transforming Growth Factor-Beta"
        ],
        [
          "TGFB1 gene"
        ],
        [
          "Glycogen Synthase Kinase 3"
        ],
        [
          "Protective cup"
        ],
        [
          "Critical"
        ],
        [
          "Transforming Growth Factors"
        ],
        [
          "Responsible to"
        ],
        [
          "E-Cadherin"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Blocking"
        ],
        [
          "Direct type of relationship"
        ],
        [
          "RNA, Messenger"
        ],
        [
          "Cell-cell adhesion molecule"
        ],
        [
          "Transcription Factor 7-Like 2"
        ],
        [
          "Target"
        ],
        [
          "Entire cell"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "Neoplasm Metastasis"
        ],
        [
          "Promotion (action)"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Transcription, Genetic"
        ],
        [
          "Factor"
        ],
        [
          "CST12P gene"
        ],
        [
          "Cell Invasion"
        ],
        [
          "Embryonic development aspects"
        ],
        [
          "Activation action"
        ],
        [
          "Complete"
        ],
        [
          "Binding action"
        ],
        [
          "Event"
        ],
        [
          "Interleukin-6, human"
        ],
        [
          "Phenotype determination"
        ],
        [
          "Invasive"
        ],
        [
          "Experimental Result"
        ],
        [
          "physiologic migration"
        ],
        [
          "Major"
        ],
        [
          "Correlation"
        ],
        [
          "Identified"
        ],
        [
          "Introduction procedure"
        ],
        [
          "Loss"
        ],
        [
          "Sufficient"
        ],
        [
          "Mechanism (attribute)"
        ],
        [
          "CREBZF gene"
        ],
        [
          "Tumor cells, malignant"
        ],
        [
          "acireductone dioxygenase [iron(II)-requiring] activity"
        ],
        [
          "Potential"
        ],
        [
          "Lanugo (invertebrate)"
        ],
        [
          "First (number)"
        ],
        [
          "TCF3 gene"
        ],
        [
          "S100A1 wt Allele"
        ],
        [
          "Reduced"
        ],
        [
          "Negation"
        ],
        [
          "Cell Migration Inhibition function"
        ],
        [
          "Belarus"
        ],
        [
          "Model"
        ],
        [
          "Euchromatin"
        ],
        [
          "C2H2 Zinc Finger"
        ],
        [
          "VIM gene"
        ],
        [
          "IL6 gene"
        ],
        [
          "Maxillary left central incisor abutment"
        ],
        [
          "silence"
        ],
        [
          "Singular"
        ],
        [
          "RPE gene"
        ],
        [
          "STAT3 gene"
        ],
        [
          "vimentin location"
        ],
        [
          "Zinc Fingers"
        ]
      ],
      "id": "5319abe4b166e2b80600002e",
      "ideal_answer": "We demonstrate, for the first time, that thrombin induces E-cadherin repression by stimulating snail-2 (SLUG) transcription factor expression,. Mutation of the putative GSK-3β phosphorylation sites (S92/96A or S100/104A) enhanced the Slug/Snail2-mediated EMT properties of E-cadherin repression and vimentin induction, compared with wild-type Slug/Snail2. Here, we have determined that methylation of histone H3 on lysine 9 (H3K9me2) is critical for promoter DNA methylation of E-cadherin in three TGF-β-induced EMT model cell lines, as well as in CLBC cell lines. To our knowledge, this is the first study that shows IL-6 as an inducer of an EMT phenotype in breast cancer cells and implicates its potential to promote breast cancer metastasis. Further, Snail interacted with G9a, a major euchromatin methyltransferase responsible for H3K9me2, and recruited G9a and DNA methyltransferases to the E-cadherin promoter for DNA methylation. Knockdown of Suv39H1 restored E-cadherin expression by blocking H3K9me3 and DNA methylation and resulted in the inhibition of cell migration, invasion and metastasis of BLBC. RNA interference-mediated downregulation of deltaEF1 in cancer cells was sufficient to derepress E-cadherin expression and restore cell to cell adhesion, suggesting that deltaEF1 is a key player in late stage carcinogenesis. "
    },
    {
      "exact_answer": [
        [
          "PD 173074"
        ],
        [
          "Transforming Growth Factors"
        ],
        [
          "Transforming Growth Factor Beta 1"
        ],
        [
          "Induce (action)"
        ],
        [
          "Mediator brand of benfluorex hydrochloride"
        ],
        [
          "Adenosinetriphosphatase"
        ],
        [
          "epithelial to mesenchymal transition"
        ],
        [
          "Recombinant Cytokines"
        ],
        [
          "Sodium Cation"
        ],
        [
          "Proline"
        ],
        [
          "Recombinant Tumor Necrosis Factor-Alpha"
        ],
        [
          "Gelatins"
        ],
        [
          "Somatomedins"
        ],
        [
          "Fibroblast Growth Factor Receptor 1"
        ],
        [
          "Cells"
        ],
        [
          "Growth Factor"
        ],
        [
          "SELE gene"
        ],
        [
          "K Prime"
        ],
        [
          "Neoplasm"
        ],
        [
          "Insulin-Like Growth Factor II"
        ],
        [
          "IL1B gene"
        ],
        [
          "Transforming Growth Factor beta"
        ],
        [
          "Expression procedure"
        ],
        [
          "IGF2 gene"
        ],
        [
          "Biological Markers"
        ],
        [
          "Matrix Metalloproteinases"
        ],
        [
          "Interleukin-1 beta"
        ],
        [
          "Fibroblast Growth Factor"
        ],
        [
          "Scientific Study"
        ],
        [
          "cytokine"
        ],
        [
          "Add - instruction imperative"
        ],
        [
          "Epithelial"
        ],
        [
          "Generic Role"
        ],
        [
          "Spindle"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Processed"
        ],
        [
          "CDH17 gene"
        ],
        [
          "Invasive"
        ],
        [
          "Loss"
        ],
        [
          "Insulin Receptor"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Activation action"
        ],
        [
          "Fibronectins"
        ],
        [
          "Acquisition (action)"
        ],
        [
          "Increased"
        ],
        [
          "CDH1 gene"
        ],
        [
          "Evidence of"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Oncogene Proteins"
        ],
        [
          "Extracellular Matrix"
        ],
        [
          "Mesenchymal"
        ],
        [
          "Infiltration"
        ],
        [
          "Contribution"
        ],
        [
          "Cardiac Arrest"
        ],
        [
          "AKT1 gene"
        ],
        [
          "Regulation"
        ],
        [
          "Cell Invasion"
        ],
        [
          "Limulus clotting factor C"
        ],
        [
          "combination of objects"
        ],
        [
          "suggestion"
        ],
        [
          "Recombinant Transforming Growth Factor-Beta 1"
        ],
        [
          "beta catenin"
        ],
        [
          "Recombinant Fibroblast Growth Factor 1"
        ],
        [
          "Subunit"
        ],
        [
          "Shapes"
        ],
        [
          "Promoter"
        ],
        [
          "chemokine"
        ],
        [
          "Cellular Morphology"
        ],
        [
          "Characterization"
        ],
        [
          "Phenotype"
        ],
        [
          "Tumor cells, malignant"
        ],
        [
          "Recombinant Transforming Growth Factor"
        ],
        [
          "Recombinant Transforming Growth Factor-Beta"
        ],
        [
          "Transforming Growth Factor alpha"
        ],
        [
          "Matrix Metalloproteinase 9"
        ],
        [
          "Stimulation (motivation)"
        ],
        [
          "SHH gene"
        ],
        [
          "Rapid"
        ],
        [
          "Immune"
        ],
        [
          "Fibroblasts"
        ],
        [
          "Internal-External Locus of Control Scale"
        ],
        [
          "Mixture"
        ],
        [
          "Diversity"
        ],
        [
          "Pancreatic carcinoma"
        ],
        [
          "Mitogen-Activated Protein Kinase 3"
        ],
        [
          "Tubular cells"
        ],
        [
          "Inhibited"
        ],
        [
          "Extracellular Signal Regulated Kinases"
        ],
        [
          "Biochemical Pathway"
        ],
        [
          "Reduced"
        ],
        [
          "Insulin-Like Growth Factor I"
        ],
        [
          "Ligands"
        ],
        [
          "Transcription Factor AP-1"
        ],
        [
          "Blood group antibody I"
        ],
        [
          "Function"
        ],
        [
          "Does play"
        ],
        [
          "Providing (action)"
        ],
        [
          "Associated with"
        ],
        [
          "Pancreas"
        ],
        [
          "Cultured Cell Line"
        ]
      ],
      "id": "5319abffb166e2b80600002f",
      "ideal_answer": "Among these factors, fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including FGFR1-4. In contrast, Akt1 down-regulation in IGF-IR-stimulated cells promoted dramatic neomorphic effects characteristic of an epithelial-mesenchymal transition (EMT) and enhanced cell migration induced by IGF-I or EGF stimulation. Furthermore, treatment of HOC313 cells with PD173074 suppressed cellular proliferation and invasion and reduced ERK1/2 and p38 activation. In addition, the expression levels of certain matrix metalloproteinases (MMPs), whose genes contain activator protein-1 (AP-1) promoter sites, as well as Snail1 and Snail2 were reduced following PD173074 treatment. Previous studies have shown that Na,K-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-β1-mediated EMT in kidney cells. In A549 lung adenocarcinoma cells, TGF-β elicited EMT in Smad-dependent manner and TNF-α accelerated this process, as confirmed by cell morphology, expression of EMT markers, capacity of gelatin lysis and cell invasion. In this study, we report that cytomix (a mixture of IL-1beta, TNF-alpha and IFN-gamma) significantly enhances TGF-beta1-induced EMT in A549 cells as evidenced by acquisition of fibroblast-like cell shape, loss of E-cadherin, and reorganization of F-actin. "
    },
    {
      "exact_answer": "yes",
      "id": "5319ac18b166e2b806000030",
      "ideal_answer": "Here we show that E-cadherin polarity is controlled by the polarized regulation of clathrin- and dynamin-mediated endocytosis. We demonstrated that GnT-III induced a stabilizing effect on E-cadherin at the cell membrane by inducing a delay in the turnover rate of the protein, contributing for the formation of stable and functional adherens-junctions, and further preventing clathrin-dependent E-cadherin endocytosis. We found that in this experimental system E-cadherin entered a transferrin-negative compartment before transport to the early endosomal compartment, where it merged with classical clathrin-mediated uptake pathways. We delineate a pathway that controls the initiation of E-cadherin endocytosis through the regulation of AP2 and clathrin coat recruitment by E-cadherin. The increased endocytosis was clathrin-dependent, because it was blocked by expression of a dominant-negative form of dynamin or by hypertonic shock. E-cadherin is a central component of the adherens junction in epithelial cells and continuously undergoes endocytosis via clathrin-coated vesicles and/or caveolae depending on the cell type. Consistent with these observations, we found that selective uncoupling of p120 from E-cadherin by introduction of amino acid substitutions in the p120-binding site increased the level of E-cadherin endocytosis. "
    },
    {
      "exact_answer": [
        [
          "Triphosphatase"
        ],
        [
          "GIT1 protein, human"
        ],
        [
          "Guanosine"
        ],
        [
          "S1PR1 gene"
        ],
        [
          "lamellipodium assembly"
        ]
      ],
      "id": "5319ac36b166e2b806000031",
      "ideal_answer": "Deletion of edg-1 or inhibition of sphingosine kinase suppressed chemotaxis toward PDGF and also activation of the small guanosine triphosphatase Rac, which is essential for protrusion of lamellipodia and forward movement. We found that fibroblasts from EDG-1 null embryos did not migrate toward PDGF or SPP, and inhibition of motility correlated with defective activation of the small guanosine triphosphatase Rac, which is required for lamellipodia formation and directional locomotion. The mechanisms involved extracellular signal-regulated kinases 1 and 2-mediated Cortactin-S405 phosphorylation and activation of Rac1/Cdc42. We specifically identified that the Spa homology domain (aa 250-420) of GIT1 is required for GIT1-cortactin complex localization to the leading edge. We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination. Evidence from these models indicates that migration is a highly complex process, which is likely to involve the tightly controlled spatial and temporal interaction of multiple factors:. Rac), which allows the formation of specialized cellular processes termed lamellipodia. (v) molecules which regulate cytoskeletal function (e.g. "
    },
    {
      "id": "5319ac7fb166e2b806000033",
      "ideal_answer": "Moreover, Twist plays an important role in some physiological processes involved in metastasis, like angiogenesis, invadopodia, extravasation, and chromosomal instability. Transforming growth factor β (TGF-β)-stimulated epithelial-mesenchymal transition (EMT) is an important developmental process that has also been implicated in increased cell invasion and metastatic potential of cancer cells. Herein, we demonstrate that TGF-β-induced Hic-5 up-regulation or ectopic expression of Hic-5 in normal MCF10A cells promoted increased extracellular matrix degradation and invasion through the formation of invadopodia. We recently found that the transcription factor Twist1, a central regulator of the epithelial-mesenchymal transition (EMT), promotes invadopodia formation via upregulation of platelet-derived growth factor receptor (PDGFR) expression and activity. These data identify Hic-5 as a critical mediator of TGF-β-stimulated invadopodia formation, cell migration, and invasion. In a process of epithelial-mesenchymal transition (EMT), besides changing their adhesive repertoire, cancer cells employ developmental processes to gain migratory and invasive properties that involve a dramatic reorganization of the actin cytoskeleton and the concomitant formation of membrane protrusions required for invasive growth. The A431-III cells possess higher invasive and migratory abilities, elevated levels of MMP-9 and an enhanced epithelial-mesenchymal transition (EMT) phenotype. Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. "
    },
    {
      "exact_answer": [
        [
          "tuberous sclerosis complex 2 protein"
        ],
        [
          "CCL26 wt Allele"
        ],
        [
          "TBC1D7 gene"
        ],
        [
          "Esthesia"
        ],
        [
          "complex (molecular entity)"
        ]
      ],
      "id": "5319ac99b166e2b806000034",
      "ideal_answer": "Here, we identify and biochemically characterize TBC1D7 as a stably associated and ubiquitous third core subunit of the TSC1-TSC2 complex. TBC1D7 knockdown decreases the association of TSC1 and TSC2 leading to decreased Rheb-GAP activity, without effects on the localization of TSC2 to the lysosome. We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity. Like the other TSC-TBC components, TBC1D7 knockdown results in increased mTORC1 signaling, delayed induction of autophagy, and enhanced cell growth under poor growth conditions. The tuberous sclerosis complex (TSC) tumor suppressors form the TSC1-TSC2 complex, which limits cell growth in response to poor growth conditions. Through its GTPase-activating protein (GAP) activity toward Rheb, this complex inhibits the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1), a key promoter of cell growth. "
    },
    {
      "exact_answer": [
        [
          "Proteins"
        ],
        [
          "DNAJC11 gene"
        ],
        [
          "CHCHD3 gene"
        ],
        [
          "Membrane Proteins"
        ],
        [
          "Negation"
        ]
      ],
      "id": "531e2695267d7dd05300000f",
      "ideal_answer": "DnaJC11, respectively. The first three are outer membrane proteins, CHCHD3 has been assigned to the matrix space, and the other two proteins have not been described in mitochondria previously. "
    },
    {
      "exact_answer": [
        [
          "Flavivirus"
        ],
        [
          "Type - attribute"
        ],
        [
          "Genus"
        ],
        [
          "Ticks"
        ],
        [
          "Flaviviridae"
        ],
        [
          "Country of Bulgaria"
        ],
        [
          "Yellow Fever Vaccine"
        ],
        [
          "Austria"
        ],
        [
          "Availability of"
        ],
        [
          "Exist"
        ],
        [
          "Pestivirus"
        ],
        [
          "Species"
        ],
        [
          "Suborder Ixodides"
        ],
        [
          "Protons"
        ],
        [
          "suggestion"
        ],
        [
          "Preposition For"
        ],
        [
          "Ursidae Family"
        ],
        [
          "Europe"
        ],
        [
          "Country"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Hepatitis C-Like Viruses"
        ],
        [
          "Negation"
        ],
        [
          "public health medicine (field)"
        ],
        [
          "Extensive"
        ],
        [
          "Culicidae"
        ],
        [
          "Iodides"
        ],
        [
          "Slovenia"
        ],
        [
          "Flavivirus Infections"
        ],
        [
          "Incidence Rate"
        ],
        [
          "Arthropod Vectors"
        ],
        [
          "Czech Republic"
        ],
        [
          "coverage - financial contract"
        ],
        [
          "Smear - instruction imperative"
        ],
        [
          "Fluctuation"
        ],
        [
          "Abnormally high"
        ],
        [
          "Major"
        ],
        [
          "Tick-Borne Encephalitis"
        ],
        [
          "Encephalitis"
        ],
        [
          "Japanese Encephalitis"
        ],
        [
          "Viral meningitis"
        ],
        [
          "Asia"
        ],
        [
          "Industrial machine"
        ],
        [
          "Consistency"
        ],
        [
          "Yellow fever virus"
        ],
        [
          "geographic population"
        ],
        [
          "Bovine viral diarrhea"
        ],
        [
          "Cessation of life"
        ],
        [
          "Cloning Vectors"
        ],
        [
          "Central Europe"
        ],
        [
          "Transmitted by"
        ],
        [
          "Annual"
        ],
        [
          "Mass Vaccination"
        ],
        [
          "Vaccination"
        ],
        [
          "Largest"
        ],
        [
          "Decade"
        ],
        [
          "Concern"
        ],
        [
          "Variant"
        ],
        [
          "Etiology"
        ],
        [
          "RNA Viruses"
        ],
        [
          "Entire cell"
        ],
        [
          "Vaccine - EntityCode"
        ],
        [
          "Persons"
        ],
        [
          "Hepatitis C virus"
        ],
        [
          "consider"
        ],
        [
          "Illness (finding)"
        ],
        [
          "Eye"
        ],
        [
          "Physical Shift"
        ],
        [
          "Date in time"
        ],
        [
          "Effectiveness"
        ],
        [
          "morbidity aspects"
        ],
        [
          "Viral"
        ],
        [
          "therapeutic aspects"
        ],
        [
          "Host (organism)"
        ],
        [
          "Infected"
        ],
        [
          "Problem"
        ],
        [
          "Behavior"
        ],
        [
          "Comparison"
        ],
        [
          "Combined result"
        ],
        [
          "Research Activities"
        ],
        [
          "incidence of cases"
        ],
        [
          "Patients"
        ],
        [
          "Assessed"
        ],
        [
          "Distribution"
        ],
        [
          "Age Distribution"
        ],
        [
          "Virus"
        ],
        [
          "Exposure to"
        ],
        [
          "Family"
        ],
        [
          "Increasing"
        ],
        [
          "Previous"
        ],
        [
          "Study"
        ],
        [
          "Experimental Result"
        ],
        [
          "Detected (finding)"
        ],
        [
          "acute"
        ],
        [
          "Order (arrangement)"
        ],
        [
          "Decreased"
        ],
        [
          "Range"
        ],
        [
          "complex (molecular entity)"
        ],
        [
          "Small"
        ],
        [
          "year"
        ],
        [
          "Factor"
        ]
      ],
      "id": "532083389b2d7acc7e000003",
      "ideal_answer": "Despite the extensive research and public health concern associated with flavivirus diseases, to date, there is no specific treatment available for any flavivirus infections, though commercially available vaccines for yellow fever, Japanese encephalitis and tick-born encephalitis exist. Considering the remarkable increase in TBE morbidity in Europe over the past two decades, we conducted a study of TBE among patients with acute viral meningitis who were hospitalised in Bulgaria during 2009 to 2012. For all 3 countries we found extensive annual and longer range fluctuations and shifts in distribution of patient ages, suggesting major variations in the complex interplay of factors influencing risk for exposure to TBE virus. The Flaviviridae family consists of 3 genera which include the Flavivirus genus (type species, yellow fever virus) as the largest genus, the Hepacivirus (type species, hepatitis C virus) and the Pestivirus (type species, bovine virus diarrhea). The flaviviruses (Flavivirus genus) are small RNA viruses transmitted by mosquitoes and ticks that take over host cell machinery in order to propagate. To assess the effect of increasing TBE vaccination coverage in Austria, we compared incidence rates over 40 years for highly TBE-endemic countries of central Europe (Czech Republic, Slovenia, and Austria). "
    },
    {
      "exact_answer": "yes",
      "id": "5321b8579b2d7acc7e000008",
      "ideal_answer": "The protocols detailed in this unit are used to purify three recombinant enzymes that are widely used in HCV research: the HCV NS3 protease domain, the helicase domain as an NS3+NS4A complex, and the NS5B RNA-dependent RNA polymerase. Results showed that stimulation of CSFV NS5B RdRp activity was obtained by NS3 binding to NS5B through a 31-amino acid fragment at the N-terminal end of NS3 protease domain, which mediated a specific NS3-NS5B interaction. Popular targets related to translation and replication are the NS3/4A protease (inhibited by telaprevir and boceprevir) and the NS5B polymerase, as well as the NS2/3 autoprotease, the NS3 helicase, and nonenzymatic targets such as NS4B and NS5A proteins. To investigate the effect of NS3 on classical swine fever virus (CSFV) NS5B RNA-dependent RNA polymerase activity (RdRp) activity and NS3-NS5B interaction, RdRp reactions, GST-pull-down assays and co-immunoprecipitation analyses containing NS5B and either of NS3 protein and the different truncated NS3 mutants were performed, respectively. The NS3 helicase domain competes with NS3 full-length for NS5 RdRp binding, with a K(d.) of 2.5μM. Several labs have obtained evidence for a protein complex that involves many of the nonstructural (NS) proteins encoded by the virus. "
    },
    {
      "exact_answer": [
        [
          "CDISC SDTM Yes No Unknown or Not Applicable Response Terminology"
        ],
        [
          "ADAM11 Protein"
        ],
        [
          "Androgens"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Interferons"
        ],
        [
          "Triglyceride storage disease with ichthyosis"
        ],
        [
          "Primary operation"
        ],
        [
          "Malignant neoplasm of prostate"
        ],
        [
          "Neoplasm"
        ],
        [
          "Recombinant Cytokines"
        ],
        [
          "tartrate-resistant acid phosphatase"
        ],
        [
          "Expression procedure"
        ],
        [
          "Experimental Result"
        ],
        [
          "PSCA Protein"
        ],
        [
          "Abnormally high"
        ],
        [
          "Proline"
        ],
        [
          "Rats, Inbred Lew"
        ],
        [
          "Immunotherapy"
        ],
        [
          "Support, device"
        ],
        [
          "Immunosuppressive Agents"
        ],
        [
          "Tumor Necrosis Factors"
        ],
        [
          "Vaccination"
        ],
        [
          "Recombinant Interleukin-12"
        ],
        [
          "Response process"
        ],
        [
          "Assortment"
        ],
        [
          "Trap medical device"
        ],
        [
          "Toll-like receptors"
        ],
        [
          "Vaccines, DNA"
        ],
        [
          "Dependent - ability"
        ],
        [
          "Organism Strain"
        ],
        [
          "Model"
        ],
        [
          "tumor growth"
        ],
        [
          "Tumor Antigens"
        ],
        [
          "Promoter"
        ],
        [
          "Clinical"
        ],
        [
          "Including (qualifier)"
        ],
        [
          "Analysis"
        ],
        [
          "Rats, Transgenic"
        ],
        [
          "In Blood"
        ],
        [
          "novel AODU treatment method"
        ],
        [
          "CLEC4C gene"
        ],
        [
          "StemRegenin 1"
        ],
        [
          "Generation (action)"
        ],
        [
          "CLEC9A gene"
        ],
        [
          "THBD wt Allele"
        ],
        [
          "ACPP gene"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "probasin"
        ],
        [
          "Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE Term"
        ],
        [
          "CD1C gene"
        ],
        [
          "NRP1 gene"
        ],
        [
          "Belarus"
        ],
        [
          "Rattus norvegicus"
        ],
        [
          "Numeric Pain Scale"
        ],
        [
          "Malignant - descriptor"
        ],
        [
          "AHR gene"
        ],
        [
          "Penetrance"
        ],
        [
          "Epithelioid Cell Melanoma"
        ],
        [
          "Castration"
        ],
        [
          "SV40 T-antigen"
        ],
        [
          "Comprehension"
        ],
        [
          "Add - instruction imperative"
        ],
        [
          "suggestion"
        ],
        [
          "CD34 Measurement"
        ],
        [
          "Rats, Inbred Strains"
        ],
        [
          "Overall Publication Type"
        ],
        [
          "compromise"
        ],
        [
          "immunologic"
        ],
        [
          "Prostatic Neoplasms"
        ],
        [
          "Hereditary pancreatitis"
        ],
        [
          "Tumor Microenvironment"
        ],
        [
          "Neoplasm Metastasis"
        ],
        [
          "combination of objects"
        ],
        [
          "Subgroup"
        ],
        [
          "Encode (action)"
        ],
        [
          "Preclinical"
        ],
        [
          "Leukocytes"
        ],
        [
          "Specimen"
        ],
        [
          "promise"
        ],
        [
          "Subtype (attribute)"
        ],
        [
          "Myeloid"
        ],
        [
          "Vaccine Potency"
        ],
        [
          "Hematopoietic stem cells"
        ],
        [
          "ex vivo"
        ],
        [
          "Adenocarcinoma of prostate"
        ],
        [
          "melanoma"
        ],
        [
          "Acquisition (action)"
        ],
        [
          "Transgenic Model"
        ],
        [
          "Qualitative form"
        ],
        [
          "Human maturation"
        ],
        [
          "Ligands"
        ],
        [
          "Frequencies (time pattern)"
        ],
        [
          "Scientific Study"
        ],
        [
          "Prostate specific"
        ],
        [
          "Prostate"
        ],
        [
          "Suppressed"
        ],
        [
          "Metastatic to"
        ],
        [
          "Antagonist muscle action"
        ],
        [
          "Antigens"
        ],
        [
          "Characterization"
        ]
      ],
      "id": "5321badd9b2d7acc7e00000a",
      "ideal_answer": "odent models of prostate cancer have served as valuable preclinical models to evaluate novel treatments and understand malignant disease progression. In addition, our results show that the epithelioid subtype of melanoma has the highest incidence of NY-ESO-1 expression. Our results support previous findings showing higher expression of NY-ESO-1 in metastatic (58/206; 28.2%) versus primary (0/16) tumors. Pre-clinical studies suggest that vaccination with combination of primary DC subsets, such as myeloid and plasmacytoid blood DCs (mDCs and pDCs, respectively), may result in stronger clinical responses. However, it is a challenge to obtain high enough numbers of primary DCs for immunotherapy, since their frequency in blood is very low. Here, we show that by inhibiting the aryl hydrocarbon receptor with its antagonist StemRegenin 1 (SR1), clinical-scale numbers of functional BDCA2(+)BDCA4(+) pDCs, BDCA1(+) mDCs, and BDCA3(+)DNGR1(+) mDCs can be efficiently generated from human CD34(+) HPCs. Finally, we demonstrate that Lew-TRAP rats could be immunized with a DNA vaccine encoding a human prostate tumor antigen (prostatic acid phosphatase) with the development of Lewis strain-specific T-cell responses. "
    },
    {
      "id": "5321bc029b2d7acc7e00000c",
      "ideal_answer": "We showed that transfer Socs1-silenced or tumour antigen TRP2 persistent expressed DCs, or DCs modified by combination of Socs1-silencing and sustaining TRP2 expression prior to inoculation of tumour cells delayed B16 tumour cell growth, prolonged mouse survival and increased the ratio of CD8+ T/Treg as well as the CTL activity in tumours. In this study, we explored the anti-tumour immunity of DCs modified by Socs1-shRNA lentiviral transduction combined with sustained expression of TRP2 in different tumour models. We generated a plasmid encoding non-cleavable human CD40L mutant (pcDNA3.1+-CD40L-M) to determine the direct anti-proliferative and pro-apoptotic effects in CD40-positive lung adenocarcinoma cell line A549, to verify activation of immature dentritic cells (DCs) by co-cultivation with the transfected A549 cells and to evaluate the lower expression of sCD40L relative to that of wild-type CD40L (CD40L-WT) transfectant in cell-free supernatants. Clinical trials are currently underway evaluating anti-sense oligonucleotides against Survivin, immunotherapy using Survivin primed dentritic cells and peptide mimics that block interaction of Survivin with Hsp90 resulting in loss of Survivin protein stability. Additional approaches using ribozymes against Survivin mRNA, or dominant-negative cDNA to block Survivin function are in pre-clinical stages. "
    },
    {
      "exact_answer": [
        [
          "Tubulin"
        ],
        [
          "histone deacetylase 6"
        ],
        [
          "Deacetylase"
        ],
        [
          "Protein Acetylation"
        ],
        [
          "SIRT2 gene"
        ],
        [
          "Microtubules"
        ],
        [
          "HDAC6 gene"
        ],
        [
          "ATAT1 wt Allele"
        ],
        [
          "Angiotensin II"
        ],
        [
          "Niacinamide"
        ],
        [
          "Induce (action)"
        ],
        [
          "suggestion"
        ],
        [
          "Axonal degeneration"
        ],
        [
          "Histone Deacetylase"
        ],
        [
          "Ethanol"
        ],
        [
          "Experimental Result"
        ],
        [
          "Nicotinamide adenine dinucleotide (NAD)"
        ],
        [
          "Histone deacetylase inhibitor"
        ],
        [
          "sirtinol"
        ],
        [
          "Resistant (qualifier value)"
        ],
        [
          "Generic Role"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Percent inhibition"
        ],
        [
          "microtubule binding"
        ],
        [
          "Losartan"
        ],
        [
          "Mediator brand of benfluorex hydrochloride"
        ],
        [
          "Dietary Lead"
        ],
        [
          "Singular"
        ],
        [
          "Nocodazole"
        ],
        [
          "Pan Genus"
        ],
        [
          "Extent"
        ],
        [
          "Inhibitor"
        ],
        [
          "Blocking"
        ],
        [
          "Depletion"
        ],
        [
          "trichostatin A"
        ],
        [
          "Cells"
        ],
        [
          "tubulin deacetylation"
        ],
        [
          "Acyltransferase"
        ],
        [
          "RNA, Small Interfering"
        ],
        [
          "Treated with"
        ],
        [
          "Logical Condition"
        ],
        [
          "Increased"
        ],
        [
          "Add - instruction imperative"
        ],
        [
          "Increase"
        ],
        [
          "Poly(ADP-ribose) polymerase inhibitor"
        ],
        [
          "granule cell"
        ],
        [
          "control substance"
        ],
        [
          "PREVENT (product)"
        ],
        [
          "pharmacological"
        ],
        [
          "Cerebral cortex"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Active"
        ],
        [
          "Receptor, Angiotensin, Type 1"
        ],
        [
          "Proteins"
        ],
        [
          "Impaired"
        ],
        [
          "Levels (qualifier value)"
        ],
        [
          "physiological aspects"
        ],
        [
          "Protein Overexpression"
        ],
        [
          "Does play"
        ],
        [
          "Reduced"
        ],
        [
          "Study"
        ],
        [
          "KIAA1279 gene"
        ],
        [
          "Major"
        ],
        [
          "Hat - Headwear"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Lower - spatial qualifier"
        ],
        [
          "Negation"
        ],
        [
          "Distributing"
        ],
        [
          "Wild Type Unspecified - zebrafish"
        ],
        [
          "Integer +2"
        ],
        [
          "Deacetylation"
        ],
        [
          "Frontotemporal dementia"
        ],
        [
          "Disassembly (action)"
        ],
        [
          "NAD-dependent histone deacetylase activity"
        ],
        [
          "deacetylase activity"
        ],
        [
          "Stretching exercises"
        ],
        [
          "Redistribution"
        ],
        [
          "Discover"
        ],
        [
          "Histone Acetylation"
        ],
        [
          "Extrinsic"
        ],
        [
          "Presynaptic Terminals"
        ],
        [
          "Approximate"
        ],
        [
          "Microtubule alteration"
        ],
        [
          "microtubule cytoskeleton organization"
        ],
        [
          "Cerebellum"
        ],
        [
          "Granules"
        ],
        [
          "Promotion (action)"
        ],
        [
          "physiologic migration"
        ],
        [
          "Cloning Vectors"
        ],
        [
          "Usual"
        ],
        [
          "neuron migration"
        ],
        [
          "Protein Isoforms"
        ],
        [
          "blood vessel remodeling"
        ],
        [
          "Instability"
        ],
        [
          "Modulated"
        ],
        [
          "Hypertensive disease"
        ],
        [
          "Cold Temperature"
        ],
        [
          "Mammals"
        ],
        [
          "RNA Interference"
        ],
        [
          "Functional Map"
        ]
      ],
      "id": "5322d3cb9b2d7acc7e000010",
      "ideal_answer": "In this study, angiotensin II induced disassembly and deacetylation of α-tubulin, which were blocked by pretreatment with an angiotensin II type 1 receptor blocker losartan and a sirtuin class deacetylase inhibitor sirtinol, and by depletion of a deacetylase SIRT2 using RNA interference. Nicotinamide but not 3-aminobenzamide, an inhibitor for poly(ADP)ribose polymerase, enhanced tubulin acetylation and resistance to axonal degeneration in cultured cerebellar granule cells from wild-type (WT) mice, suggesting that mammalian Sir2-related protein (SIRT) 2, a nicotinamide adenine dinucleotide (NAD)--dependent tubulin deacetylase, could modulate resistance to axonal degeneration. Interestingly, HDAC6 from ethanol-treated cells was able to bind and deacetylate exogenous tubulin to the same extent as control, suggesting that ethanol-induced tubulin modifications prevented HDAC6 binding to endogenous microtubules. The results also showed that both pan-HDAC and class-I-specific inhibitor treatment resulted in increased acetylation of histones, but only pan-HDAC inhibitor treatment resulted in increased tubulin acetylation, which is in agreement with their activity towards the HDAC6 isoform. We found that whereas both pharmacological inhibition of HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC6 activity leads to an increase in microtubule stability against cold and nocodazole-induced depolymerizing conditions. "
    },
    {
      "exact_answer": [
        [
          "Blood Patch, Epidural"
        ],
        [
          "Puncture procedure"
        ],
        [
          "Gastrointestinal Leak Adverse Event NOS"
        ],
        [
          "Headache, Intractable"
        ],
        [
          "Spinal Puncture"
        ]
      ],
      "id": "53262cdcd6d3ac6a34000003",
      "ideal_answer": "Epidural blood patch for refractory low CSF pressure headache: a pilot study. However the present results, allows us to conclude that EBP in treatment-refractory low CSF pressure headache can be considered as a treatment option. In this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch. The weight of existing literature supports EBP as an initial treatment of SIH, although its effectiveness does not approach that seen when EBP is used to treat meningeal puncture headache. Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the site of the leak. In high-risk patients , for example, age \u003c 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed. age \u003c 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch. We describe thickening and contrast enhancement of the intracranial pachymeninges, revealed by MRI in a patient with presumed low-pressure headache following dural puncture and a blood patch. This was initially treated with analgesia, caffeine, and fluids for the presumed cerebrospinal fluid (CSF) leak. "
    },
    {
      "exact_answer": [
        [
          "PABPC1 gene"
        ],
        [
          "Binding Protein"
        ],
        [
          "Poly A"
        ],
        [
          "PABPC4 gene"
        ],
        [
          "Cytoplasm"
        ]
      ],
      "id": "5326a85ad6d3ac6a3400000b",
      "ideal_answer": "Poly(A) binding protein (PABP) binds mRNA poly(A) tails. Using mass spectrometry sequencing we identified poly(A) binding proteins-1 and -4 (PABP1 and PABP4). A family of cytoplasmic poly(A)-binding proteins (PABPs) bind the poly(A) tail and can regulate mRNA translation and stability. Cytoplasmic poly(A) binding protein 4 (PABPC4) is an RNA-processing protein that plays an important role in the regulation of gene expression. In vertebrates, poly(A) binding protein (PABP) is known to exist in five different isoforms. Cytoplasmic poly(A)-binding proteins (PABPs) regulate mRNA stability and translation. The poly(A)-binding protein (PABP) is an important translation initiation factor that binds to the polyadenylated 3\u0027 end of mRNA. Human PABP binds AU-rich RNA via RNA-binding domains 3 and 4. poly(A) binding proteins 1 and 4 (PABPC1 and PABPC4). poly(A)-binding proteins PABP1 and PABP4. poly(A)-binding protein (PABP). Cytoplasmic poly(A) binding protein 4. RNA binding proteome. "
    },
    {
      "exact_answer": [
        [
          "ETV3 gene"
        ],
        [
          "Ms. - Title"
        ],
        [
          "Recombinant Erythropoietin"
        ],
        [
          "Negation"
        ],
        [
          "Metabolic Syndrome X"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Woman"
        ],
        [
          "Unmarried person"
        ],
        [
          "Obesity"
        ],
        [
          "Heat-Shock Proteins 70"
        ],
        [
          "P prime"
        ],
        [
          "Triglycerides"
        ],
        [
          "utilization qualifier"
        ],
        [
          "Requirement"
        ],
        [
          "Loading Technique"
        ],
        [
          "Body Site Modifier - Lower"
        ],
        [
          "HSPD1 gene"
        ],
        [
          "Diabetes Mellitus, Non-Insulin-Dependent"
        ],
        [
          "Patients"
        ],
        [
          "Recombinant 70-kD Heat-Shock Protein"
        ],
        [
          "High Density Lipoproteins"
        ],
        [
          "Cell fusing agent virus"
        ],
        [
          "Gender"
        ],
        [
          "User Group"
        ],
        [
          "Severity score"
        ],
        [
          "Contribution"
        ],
        [
          "Reaching"
        ],
        [
          "Associated with"
        ],
        [
          "Uric Acid"
        ],
        [
          "Increase"
        ],
        [
          "Risk"
        ],
        [
          "Albumins"
        ],
        [
          "Cluster"
        ],
        [
          "Observation parameter"
        ],
        [
          "Psoriasis"
        ],
        [
          "Publications"
        ],
        [
          "Iron"
        ],
        [
          "Serious"
        ],
        [
          "C-reactive protein"
        ],
        [
          "Not Hispanic or Latino"
        ],
        [
          "Adult"
        ],
        [
          "Amenorrhea"
        ],
        [
          "Levels (qualifier value)"
        ],
        [
          "Equation"
        ],
        [
          "Factor"
        ],
        [
          "Waist circumference (observable entity)"
        ],
        [
          "Glucose"
        ],
        [
          "Diagnosis"
        ],
        [
          "Racial group"
        ],
        [
          "Syndrome"
        ],
        [
          "Continuous"
        ],
        [
          "Black race"
        ],
        [
          "Body Composition"
        ],
        [
          "cardiovascular risk factor"
        ],
        [
          "ethnic"
        ],
        [
          "Ethnic group"
        ],
        [
          "INSULIN RESISTANCE (allelic variant)"
        ],
        [
          "Heat shock protein 60 Ab"
        ],
        [
          "Component object"
        ],
        [
          "Hemoglobin"
        ],
        [
          "Anemia"
        ],
        [
          "Delta (difference)"
        ],
        [
          "Male gender"
        ],
        [
          "Values"
        ],
        [
          "DIABETIC"
        ],
        [
          "Experimental Result"
        ],
        [
          "month"
        ],
        [
          "Methods"
        ],
        [
          "Clinical"
        ],
        [
          "trioxatriangulenium"
        ],
        [
          "Report (document)"
        ],
        [
          "P Blood group antibodies"
        ],
        [
          "2010s"
        ],
        [
          "Reverend"
        ],
        [
          "Preposition For"
        ],
        [
          "CYGB gene"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Lower - spatial qualifier"
        ],
        [
          "teratologic"
        ],
        [
          "Roman Numeral III"
        ],
        [
          "Gram per Deciliter"
        ],
        [
          "Dyslipidemias"
        ],
        [
          "Dispense Method - Traditional"
        ],
        [
          "criteria"
        ],
        [
          "Severities"
        ],
        [
          "Individuality"
        ],
        [
          "Bioelectric Impedance Analysis"
        ],
        [
          "Alopecia Areata"
        ],
        [
          "Anthropometry"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Hispanics"
        ],
        [
          "Hypertriglyceridemia"
        ],
        [
          "Pearson Correlation Test"
        ],
        [
          "Singular"
        ],
        [
          "Thyroiditis"
        ],
        [
          "Hispanic black finding"
        ],
        [
          "Abnormally high"
        ],
        [
          "Abnormally low (qualifier value)"
        ],
        [
          "Discover"
        ],
        [
          "Ethnicity aspects"
        ]
      ],
      "id": "5326c6fed6d3ac6a3400000c",
      "ideal_answer": "bolic syndrome (MS) components, such as dyslipidemia, prothrombotic status, and increased blood pressure, are risk factors for patients with renal disease. MS patients also required lower rHuEPO for reaching similar Hgb levels compared with patients without MS (2679.3 ± 1936.1 vs 3702.5 ± 2213.0 U/kg/6 mo; P \u003d .02). We investigated the effects of body compositions and MS on anemia parameters and recombinant human erythropoietin (rHuEPO) requirements in maintenance hemodialysis patients. RESULTS: Patients with the MS seem to reach target Hgb levels more frequently (10-12 g/dL; 66.3% vs 84.8%; P \u003d .03). RESEARCH DESIGN AND METHODS: Using data on adults from the National Health and Nutrition Examination Survey 1999-2010, we performed a CFA of a single MetS factor that allowed differential loadings across groups, resulting in a sex and race/ethnicity-specific continuous MetS severity score. CONCLUSIONS: This analysis among adults uniquely demonstrated differences between sexes and racial/ethnic groups regarding contributions of traditional MetS components to an assumed single factor. Our goals were to use confirmatory factor analysis (CFA) to delineate differential contributions to MetS by sub-group, and if contributions were discovered, develop sex and racial/ethnic-specific equations to calculate MetS severity. "
    },
    {
      "exact_answer": [],
      "id": "532819afd6d3ac6a3400000f",
      "ideal_answer": ""
    },
    {
      "exact_answer": [
        [
          "Superkingdom (taxonomic category)"
        ],
        [
          "Noonan Syndrome 5"
        ],
        [
          "Methyltransferase"
        ],
        [
          "RNA-directed RNA polymerase activity"
        ],
        [
          "Staphylococcal Protein A"
        ]
      ],
      "id": "532aad53d6d3ac6a34000010",
      "ideal_answer": "flavivirus NS5 harbors a methyltransferase (MTase) in its N-terminal ≈ 265 residues and an RNA-dependent RNA polymerase (RdRP) within the C-terminal part. The N-terminal domain participates in the synthesis of a mRNA cap 1 structure ((7Me)GpppA(2\u0027OMe)) at the 5\u0027 end of the viral genome and possesses guanylyltransferase, guanine-N7-methyltransferase, and nucleoside-2\u0027O-methyltransferase activities. To gain more insight into the structure of NS5 and interactions between the MTase and RdRp domains, we generated a panel of seven monoclonal antibodies (mAbs) to the NS5 protein of WNV (Kunjin strain) and mapped their binding sites using a series of truncated NS5 proteins and synthetic peptides. One of the major interests and challenges in NS5 is to understand the interplay between RdRP and MTase as a unique natural fusion protein in viral genome replication and cap formation. The C-terminal domain is an RNA-dependent RNA polymerase responsible for viral RNA synthesis. This is consistent with the ability of these mAbs to inhibit RdRp activity in vitro and suggests that this region represents a potential target for RdRp inhibitors. "
    },
    {
      "id": "532ad531d6d3ac6a34000013",
      "ideal_answer": "Secondary structure formation, measured by H/D-exchange protection, of a mutant scFv fragment of an antibody after short incubation in 6 M guanidinium chloride was shown to be multiphasic. In the presence of cyclophilin, however, the faster of the two phases vanishes (when followed by intrinsic tryptophan fluorescence), while the slower phase is not significantly enhanced by equimolar cyclophilin. Interface formation in a folding intermediate of the scFv fragment is proposed to prevent the back-isomerization of these prolines from being efficiently catalyzed by cyclophilin. e formation of an early intermediate, which shows amide-proton exchange protection, is independent of proline isomerization. Subsequently, a proline cis-trans isomerization reaction in the rapidly formed intermediate, producing \u0027non-native\u0027 isomers, competes with the fast formation of native species. Subsequently, the folding reaction proceeds via a biphasic reaction and mass spectrometry analyses of the exchange experiments confirm the existence of two parallel pathways. NMR analysis shows that an intermediate with significant proton protection is observed within the dead time of the manual mixing experiments. Antibodies are prototypes of multimeric proteins and consist of structurally similar domains. "
    },
    {
      "exact_answer": [
        [
          "M NOS ANTIBODY"
        ],
        [
          "bleomycetin"
        ],
        [
          "Chordoma"
        ],
        [
          "Etoposide"
        ],
        [
          "Tretinoin"
        ],
        [
          "Stat3 protein"
        ],
        [
          "Lipiodol"
        ],
        [
          "Cisplatin"
        ],
        [
          "SD 1029"
        ],
        [
          "Preposition For"
        ],
        [
          "Sacrococcygeal chordoma"
        ],
        [
          "fludarabine"
        ],
        [
          "Intratumoral"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Vincristine"
        ],
        [
          "Reduced"
        ],
        [
          "Doxorubicin"
        ],
        [
          "bortezomib"
        ],
        [
          "Numbers"
        ],
        [
          "Percutaneous"
        ],
        [
          "Concentration measurement"
        ],
        [
          "Patients"
        ],
        [
          "Recurrent"
        ],
        [
          "combination of objects"
        ],
        [
          "Effectiveness"
        ],
        [
          "Cells"
        ],
        [
          "Injection emulsion"
        ],
        [
          "Each (qualifier value)"
        ],
        [
          "Inhibited"
        ],
        [
          "Expression procedure"
        ],
        [
          "DNA Topoisomerases, Type I"
        ],
        [
          "Pathway (interactions)"
        ],
        [
          "Potential"
        ],
        [
          "Anatomical site notation for tumour staging PLE"
        ],
        [
          "Aftercare"
        ],
        [
          "Anthropological Culture"
        ],
        [
          "Forecast of outcome"
        ],
        [
          "Fluoroscopic guidance"
        ],
        [
          "Singular"
        ],
        [
          "Fluoroscopy"
        ],
        [
          "Emulsions"
        ],
        [
          "Money or percentage indicator - Percentage"
        ],
        [
          "Derivation"
        ],
        [
          "Stat3 Signaling Pathway"
        ],
        [
          "STAT3 gene"
        ],
        [
          "Neoplasm"
        ],
        [
          "Patient Condition Code - Stable"
        ],
        [
          "The science and art of healing"
        ],
        [
          "Representation (action)"
        ],
        [
          "Visual Analog Pain Scale"
        ],
        [
          "signaling cascade"
        ],
        [
          "Cascade Device Component"
        ],
        [
          "Pharmaceutical Preparations"
        ],
        [
          "Predictor"
        ],
        [
          "Blocking"
        ],
        [
          "Viable cells"
        ],
        [
          "Viable"
        ],
        [
          "Guide Device Component"
        ],
        [
          "cytotoxicity"
        ],
        [
          "treatment options"
        ],
        [
          "Preliminary results"
        ],
        [
          "consider"
        ],
        [
          "Simultaneous"
        ],
        [
          "Protocol Agent"
        ],
        [
          "Population Median"
        ],
        [
          "Protein phosphorylation"
        ],
        [
          "Conclusion"
        ],
        [
          "Primary operation"
        ],
        [
          "month"
        ],
        [
          "Cultured Cell Line"
        ],
        [
          "partial response"
        ],
        [
          "strategy"
        ],
        [
          "inhibitors"
        ],
        [
          "Laboratory culture"
        ],
        [
          "Patient Physiological Condition"
        ],
        [
          "Alternative"
        ],
        [
          "alone - group size"
        ],
        [
          "Stable Disease"
        ],
        [
          "Injection procedure"
        ],
        [
          "Cell Proliferation"
        ],
        [
          "Proliferation (morphologic abnormality)"
        ],
        [
          "Future"
        ],
        [
          "Cell Culture Techniques"
        ],
        [
          "Activation action"
        ],
        [
          "Better"
        ],
        [
          "Tumor size"
        ],
        [
          "Decreased size"
        ],
        [
          "Three-dimensional"
        ],
        [
          "Decreased"
        ],
        [
          "Range"
        ],
        [
          "In Vitro [Publication Type]"
        ],
        [
          "expression level"
        ],
        [
          "Increase"
        ],
        [
          "follow-up"
        ],
        [
          "\u003c3 (qualifier value)"
        ],
        [
          "times/month"
        ]
      ],
      "id": "532b15ecd6d3ac6a34000014",
      "ideal_answer": "Etoposide and cisplatin, each at a concentration of 10 μM, reduced the percentage of viable chordoma cells in a more effective way when given with 1 μM ATRA simultaneously, reducing the number of viable cells to 14% and 9%, respectively. Vincristine, doxorubicin, etoposide, cisplatin, and fludarabine, each at a concentration of 10 μM, decreased the number of chordoma cells when given alone down to 11%, 0%, 30%, 67%, and 3%, respectively. The combination treatment of bortezomib with topoisomerase I and II inhibitors increased the therapeutic potency in U-CH2 and patient-derived primary cultures. The expression of Stat3 signaling cascade was inhibited in all chordoma cell lines after treatment with SD-1029. Phosphorylation of Stat3 in chordoma cells in vitro and cellular proliferation in three-dimensional culture were inhibited by SD-1029. During the follow-up (median time of 21.7 months, range 10-26 months), all the patients showed obviously reduced tumor size and VAS, and partial remission was achieved in 6 patients and stable disease (SD) in 1 patient. Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for the treatment of recurrent sacrococcygeal chordomas. Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for treatment of recurrent sacrococcygeal chordomas. "
    },
    {
      "exact_answer": "yes",
      "id": "532bf6f2d6d3ac6a34000015",
      "ideal_answer": "Our findings allude to an integration of signaling pathways that utilize γ-secretase activity, which may have significant implications for our understanding of Alzheimer\u0027s pathogenesis vis-à-vis vascular changes that set the stage for ensuing neurodegeneration. High physiological concentrations of Aβ monomer induced angiogenesis by a conserved mechanism that blocks γ-secretase processing of a Notch intermediate, NEXT, and reduces the expression of downstream Notch target genes. Aggregated forms of Aβ have a pathogenic role in Alzheimer disease and, thus, reducing the Aβ levels by inhibiting γ-secretase is a possible treatment strategy for Alzheimer disease. Nicastrin (Nct) is part of the γ-secretase complex and has been proposed to be involved in substrate recognition and selection. Since the discovery, already \u003e15 years ago, of its catalytic component, presenilin, and even much earlier with the identification of amyloid precursor protein as its first substrate, γ-secretase has been commonly associated with Alzheimer\u0027s disease. In the last decade, increasing evidence has pointed out an important role of this pathway beyond embryonic development, indicating that Notch also displays a critical function in the mature brain of vertebrates and invertebrates. "
    },
    {
      "exact_answer": "yes",
      "id": "532bf822d6d3ac6a34000016",
      "ideal_answer": "As beta-APP and Notch are both processed by gamma-secretase, we analyzed expression of the Notch signaling pathway in the adult DS brain and in a model system for DS, human trisomy 21 fibroblasts by quantitative PCR. In a forward genetic screen for mutations that alter intracellular Notch receptor trafficking in Drosophila melanogaster, we recovered mutants that disrupt genes encoding serine palmitoyltransferase and acetyl-CoA carboxylase. (PSEN1) is the major locus for mutations causing familial Alzheimer\u0027s disease (FAD) and is also mutated in Pick disease of brain, familial acne inversa and dilated cardiomyopathy. PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases. A systems biology approach to Down syndrome: identification of Notch/Wnt dysregulation in a model of stem cells aging. he Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Moreover, DS fibroblasts and Alzheimer disease cortex also show overexpression of Notch1 and Dll1, indicating that enhanced beta-APP processing found in both DS and AD could be instrumental in these changes. "
    },
    {
      "exact_answer": "yes",
      "id": "532c0946d6d3ac6a34000019",
      "ideal_answer": "Proteomics database in chronic kidney disease. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. "
    },
    {
      "id": "532f03e6d6d3ac6a34000022",
      "ideal_answer": "Therefore, the intramyocardial implantation of TGF-beta-preprogrammed CD117+ cells effectively assisted the myocardial regeneration and induced therapeutic angiogenesis, contributing to functional cardiac regeneration. We conclude that GATA-4 overexpression in MSCs increased both MSC survival and angiogenic potential in ischemic myocardium and may therefore represent a novel and efficient therapeutic approach for postinfarct remodeling. We describe here the identification of a subpopulation of primitive cells from rat heart, processing stem cell marker, c-kit and myogenic transcriptional factors, GATA-4 and MEF 2C, and cardiac specific proteins, troponin-I, alpha-sarcomeric actinin and connexin-43. These cardiac c-kit+AT2+ cells, represented approximately 0.19% of total cardiac cells in infarcted heart, were characterized by upregulated transcription factors implicated in cardiogenic differentiation (Gata-4, Notch-2, Nkx-2.5) and genes required for self-renewal (Tbx-3, c-Myc, Akt). G-CSF treatment also led to activation of signal transducer and activator of transcription-3 and induction of GATA-4 and various sarcomeric proteins such as myosin heavy chain, troponin I and desmin. Progeny of implanted cells migrated along the infarcted scar, reconstituted regenerated cardiomyocytes with incorporation into host myocardium, and inhibited cardiac remodeling with decreased scar formation. "
    },
    {
      "id": "532f043ed6d3ac6a34000023",
      "ideal_answer": "Gene expression profiling revealed decreased levels of transcription factors transforming growth factor-β/bone morphogenetic protein, serum response factor, GATA4, and myocyte enhancer factor 2, linked to increased Ca(2+)-dependent calcineurin activity and Notch1 signaling that impaired ESC differentiation. MC1568 arrests myogenesis by (i) decreasing myocyte enhancer factor 2D (MEF2D) expression, (ii) by stabilizing the HDAC4-HDAC3-MEF2D complex, and (iii) paradoxically, by inhibiting differentiation-induced MEF2D acetylation. We propose a model whereby Gli2 and MEF2C bind each other\u0027s regulatory elements, activate each other\u0027s expression and form a protein complex that synergistically activates transcription, enhancing cardiac muscle development. Finally, co-immunoprecipitation studies showed that Gli2 and MEF2C proteins formed a complex, capable of synergizing on cardiomyogenesis-related promoters containing both Gli- and MEF2-binding elements. We provide evidence that MEF2 proteins are recruited to target promoters by the cell-specific GATA transcription factors, and that MEF2 potentiates the transcriptional activity of this family of tissue-restricted zinc finger proteins. BMP-2 increased PI 3-kinase activity in these cells in a time-dependent manner, resulting in increased expression of sarcomeric myosin heavy chain (MHC) and MEF-2A. Hypertrophic agonist stimulation of neonatal ventricular cardiomyocytes increased Mef2 expression by enhancing its translation, without changing its transcription or blocking degradation of the protein. "
    },
    {
      "id": "532f0511d6d3ac6a34000024",
      "ideal_answer": "In patients with HFpEF, short-term treatment with ivabradine increased exercise capacity, with a contribution from improved left ventricular filling pressure response to exercise as reflected by the ratio of peak early diastolic mitral flow velocity to peak early diastolic mitral annular velocity. Beside its use in therapy of coronary artery disease, I(f)-channel inhibition potentially exhibits beneficial effects in systolic and diastolic heart failure as well. These beneficial effects of IVA support testing pure HR reduction in patients with diastolic heart failure. In db/db, a model of HFPEF, selective HR reduction by If-inhibition improved vascular stiffness, LV contractility, and diastolic function. Newer agents such as angiotensin receptor neprilysin inhibitor, sildenafil, and ivabradine have demonstrated benefits without improving mortality. Traditional agents with strong evidence in HFrEF have proved unsuccessful in HFpEF. Therefore, If-inhibition might be a therapeutic concept for HFPEF, if confirmed in humans. Selective HR reduction with IVA reduces DD and cardiac fibrosis in hypercholesterolemic rabbits. "
    },
    {
      "id": "532f06e6d6d3ac6a34000028",
      "ideal_answer": "The aPTT assay is relatively insensitive to dabigatran, and normal aPTT results may be observed even with therapeutic dabigatran concentrations. Although aPTT does not provide a linear response to dabigatran therapy, the presence of a completely normal PTT may exclude therapeutic dabigatran anticoagulation. High APTT might help screen for bleeding risks among patients under dabigatran, but requires future investigation. The relationship between dabigatran plasma concentrations and activated partial thromboplastin time in healthy volunteers and patients (n\u003d762) was best described with a combination of a linear model and a maximum effect (Emax) model, consistent with previous reports. Statistically significant interference could be observed with the prothrombin time (PT), activated partial thromboplastin time (aPTT) and PT/aPTT-based assays (extrinsic/intrinsic factors, APC-resistance test) as well as lupus anticoagulant testing. He had been started on dabigatran 150 mg twice a day about 4 months ago as an outpatient by his cardiologist. Dabigatran led to a dose-dependent prolongation of the clotting times in coagulometric tests and influenced the majority of the parameters measured. The APTT values became prolonged under dabigatran usage and exhibited a remarkable diversity. "
    },
    {
      "exact_answer": "yes",
      "id": "532f3e08d6d3ac6a34000034",
      "ideal_answer": "This strategy relies on direct infusion of total lipid extracts into a tandem mass spectrometer without additional separation of the individual molecular species. Top-down shotgun lipidomics relies on direct infusion of total lipid extracts into a high-resolution tandem mass spectrometer. An efficient shotgun lipidomics strategy was established and optimized for fast phospholipid profiling of viscera from three fish species: Lateolabrax japonicas, Ctenopharyngodon idellus, and Carassius auratus. shotgun lipidomics (MDMS-SL) data, which are acquired directly from lipid extracts after direct infusion. Through direct infusion of the resultant enriched solution, we identified and quantitated a variety of very-low-abundance sphingolipid classes (e.g., sphingosine, psychosine, and lysosphingomyelin) and molecular species (e.g., sphingomyelin) using electrospray ionization mass spectrometry (i.e., shotgun sphingolipidomics). direct infusion-based shotgun lipidomics approaches. shotgun lipidomic approaches that use direct infusion. In direct infusion/injection (or shotgun) lipidomics. direct infusion (shotgun lipidomics). "
    },
    {
      "exact_answer": [
        [
          "Estriol"
        ],
        [
          "Recombinant Human Chorionic Gonadotropin"
        ],
        [
          "Chorionic Gonadotropin, beta Subunit, Human"
        ],
        [
          "Alpha one fetoprotein measurement"
        ],
        [
          "Human Chorionic Gonadotropin"
        ],
        [
          "MoM"
        ],
        [
          "1+ Score, WHO"
        ],
        [
          "Maternal Relative"
        ],
        [
          "Fetal Proteins"
        ],
        [
          "Alpha-1-fetoprotein measurement, serum"
        ],
        [
          "Numerical value"
        ],
        [
          "Gender Status - Intact"
        ],
        [
          "Population Median"
        ],
        [
          "Free (available (qualifier))"
        ],
        [
          "Population Mean"
        ],
        [
          "Total"
        ],
        [
          "SCGB1D1 gene"
        ],
        [
          "alpha-Fetoproteins"
        ],
        [
          "\u003c3 (qualifier value)"
        ]
      ],
      "id": "532f49f8d6d3ac6a34000035",
      "ideal_answer": "AFP--1.18 MoM and estriol--1.29 MoM and significantly higher mean median value for the free beta-hCG. alpha-fetoprotein (AFP), 1.02 for human chorionic gonadotropin (hCG) and 1.01 for unconjugated estriol (uE3. lpha-fetoprotein (AFP), total beta human chorionic gonadotrophin (hCG) and estriol (uE(3). alpha fetoprotein (AFP), beta human chorionic gonadotropin (beta-hCG), and unconjugated estriol (uE3). alpha feto-protein, HCG and unconjugated estriol. maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol. maternal serum alpha fetoprotein, unconjugated oestriol and human chorionic gonadotrophin. alpha-fetoprotein (AFP), intact HCG and unconjugated estriol (uE3). "
    },
    {
      "exact_answer": [
        [
          "Protein complex"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "algorithm"
        ],
        [
          "Proteins"
        ],
        [
          "Staphylococcal Protein A"
        ],
        [
          "Paper Authorization"
        ],
        [
          "Cluster"
        ],
        [
          "Prediction"
        ],
        [
          "Network"
        ],
        [
          "prepulse inhibition activity"
        ],
        [
          "Processor Core"
        ],
        [
          "Potassium Ion"
        ],
        [
          "Protein-Protein Interaction"
        ],
        [
          "Anatomy, Regional"
        ],
        [
          "Proton Pump Inhibitors"
        ],
        [
          "Call (Instruction)"
        ],
        [
          "Introduces"
        ],
        [
          "complex (molecular entity)"
        ],
        [
          "Restart"
        ],
        [
          "Manuals as Topic"
        ],
        [
          "Weighing patient"
        ],
        [
          "MCC protocol"
        ],
        [
          "Negation"
        ],
        [
          "PROPOSED"
        ],
        [
          "Task"
        ],
        [
          "Data"
        ],
        [
          "Interaction"
        ],
        [
          "Random"
        ],
        [
          "Test Method"
        ],
        [
          "Comprehension"
        ],
        [
          "Structure"
        ],
        [
          "Similarity"
        ],
        [
          "Methods"
        ],
        [
          "Walking (activity)"
        ],
        [
          "concept"
        ],
        [
          "Metric"
        ],
        [
          "Comparison"
        ],
        [
          "Numerous"
        ],
        [
          "Model"
        ],
        [
          "Post-Translational Protein Processing"
        ],
        [
          "Performance"
        ],
        [
          "Extension"
        ],
        [
          "isopropyl cyanoacrylate"
        ],
        [
          "Organized"
        ],
        [
          "Detection"
        ],
        [
          "Saccharomyces cerevisiae"
        ],
        [
          "Entity"
        ],
        [
          "Data Set"
        ],
        [
          "Identification (Psychology)"
        ],
        [
          "Design"
        ],
        [
          "Observation Method - algorithm"
        ],
        [
          "Approach"
        ],
        [
          "Assessed"
        ],
        [
          "Candida albicans extract"
        ],
        [
          "Body Weight"
        ],
        [
          "Site"
        ],
        [
          "Along edge (qualifier value)"
        ],
        [
          "Quantity"
        ],
        [
          "Binding Protein"
        ],
        [
          "Binding (Molecular Function)"
        ],
        [
          "Computer software"
        ],
        [
          "TANDEM"
        ],
        [
          "Protein Component"
        ],
        [
          "statistical cluster"
        ],
        [
          "Modeling"
        ],
        [
          "Score"
        ],
        [
          "Providing (action)"
        ],
        [
          "Molecular"
        ],
        [
          "Influentials"
        ],
        [
          "Sodium Cation"
        ],
        [
          "Preposition For"
        ],
        [
          "Amino Acid Sequence"
        ],
        [
          "Functional Relationship"
        ],
        [
          "Meta"
        ],
        [
          "utilization qualifier"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "disease transmission qualifier"
        ],
        [
          "clique"
        ],
        [
          "Interprets"
        ],
        [
          "Curation"
        ],
        [
          "Fine - adjective"
        ],
        [
          "Voting"
        ],
        [
          "Eagle Indian"
        ],
        [
          "Toxic Epidermal Necrolysis"
        ],
        [
          "Empowered"
        ],
        [
          "PTMS gene"
        ],
        [
          "Semantics"
        ],
        [
          "Theses"
        ],
        [
          "literary novel"
        ],
        [
          "Venezuela"
        ],
        [
          "Pipe (object)"
        ],
        [
          "Tie (garment)"
        ],
        [
          "Forecast of outcome"
        ],
        [
          "Annotations"
        ],
        [
          "Vertex"
        ],
        [
          "Attachments (document)"
        ],
        [
          "Server (computer)"
        ],
        [
          "cohesion"
        ],
        [
          "Exertion"
        ],
        [
          "Relational Operator - Equal"
        ]
      ],
      "id": "5333f728d6d3ac6a34000041",
      "ideal_answer": "We have developed an algorithm PROCOMOSS (Protein Complex Detection using Multi-objective Evolutionary Approach based on Semantic Similarity) for partitioning the whole PPI network into clusters, which serve as predicted protein complexes. HKC mainly uses the concepts of highest k-core and cohesion to predict protein complexes by identifying overlapping clusters. We compare the performance of ProRank to some of the well known protein complex prediction methods (ClusterONE, CMC, CFinder, MCL, MCode and Core) in terms of precision and recall. Identification of protein-ligand binding site is an important task in structure-based drug design and docking algorithms. non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs) and for assessing the false positive rates of PPI detection efforts. Studying protein complexes is very important in biological processes since it helps reveal the structure-functionality relationships in biological networks and much attention has been paid to accurately predict protein complexes from the increasing amount of protein-protein interaction (PPI) data. The use of this new modeling approach enables iPTMClust to provide a confidence score per modification site that allows fine-tuning and interpreting resulting PTM predictions. "
    },
    {
      "exact_answer": "yes",
      "id": "533581f5d6d3ac6a3400004d",
      "ideal_answer": "Turcot syndrome (TS) is a rare hereditary disorder clinically characterized by the occurrence of primary tumors of the colon and the central nervous system (CNS). Turcot syndrome is an autosomal recessive disorder clinically characterized by the occurrence of primary tumors of the central nervous system and adenomatous colonic polyps during the first or second decades of life, with a spectrum of clinical features such as \"café-au-lait\" spots, axillary freckling, and hyperpigmented spots. We conclude that 1) the giant cell variant of GBM is overrepresented in TS; 2) gliosarcomas may also be encountered; and 3) survival is often favorable, despite histological anaplasia and exuberant proliferation. Of the 21 patients, 12 have died (10 after relapse, with a median time to progression for the whole series of 14 months; one with intratumoral bleeding at 40 months after diagnosis; and one affected by Turcot syndrome for duodenal cancer relapse). Although cases of Turcot\u0027s syndrome (TS) (colonic polyposis and primary brain tumour occurring in the same patient) have been previously described, association with haematological malignancy is rare. In the present case, a 60-year-old patient with glioblastoma multiforme and a history of hereditary malignomas is described as an example of a HNPCC-associated Turcot\u0027s syndrome. "
    },
    {
      "exact_answer": [
        [
          "Tricho-thiodystrophy disorder"
        ],
        [
          "Trichothiodystrophy Syndromes"
        ],
        [
          "Congenital Nonbullous Ichthyosiform Erythroderma"
        ],
        [
          "Brittle hair"
        ],
        [
          "Monogen"
        ],
        [
          "Photosensitive Trichothiodystrophy"
        ],
        [
          "Photosensitivity Adverse Event"
        ],
        [
          "Ichthyoses"
        ],
        [
          "Short stature"
        ],
        [
          "Disulfiram"
        ],
        [
          "TRICHOTHIODYSTROPHY (allelic variant)"
        ],
        [
          "Case unit dose"
        ],
        [
          "Characterization"
        ],
        [
          "Deferred"
        ],
        [
          "Syndrome"
        ],
        [
          "Mental Retardation"
        ],
        [
          "Initially"
        ],
        [
          "Identified"
        ],
        [
          "Disease"
        ],
        [
          "Rare"
        ],
        [
          "Physical assessment findings"
        ],
        [
          "Clinical Study Case"
        ],
        [
          "Term (temporal)"
        ],
        [
          "Congenital MeSH qualifier"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Ichthyosis, Congenital, with Trichothiodystrophy"
        ],
        [
          "Negation"
        ],
        [
          "Amish Brittle Hair Brain Syndrome"
        ],
        [
          "Oriental Herbs and Botanicals"
        ],
        [
          "Hypomyelination"
        ],
        [
          "Osteosclerosis"
        ],
        [
          "Neuroectoderm"
        ],
        [
          "First cousin"
        ],
        [
          "Brisk tendon reflex"
        ],
        [
          "Muscle Tonus"
        ],
        [
          "Facies"
        ],
        [
          "Dysphonia"
        ],
        [
          "Bone structure of cranium"
        ],
        [
          "physiopathological"
        ],
        [
          "String (device)"
        ],
        [
          "Hypogonadism"
        ],
        [
          "Bilateral cataracts (disorder)"
        ],
        [
          "Patchy distribution"
        ],
        [
          "Singular"
        ],
        [
          "Hair fragility"
        ],
        [
          "Derivation"
        ],
        [
          "Type - attribute"
        ],
        [
          "Nail abnormality"
        ],
        [
          "Nail dysplasia"
        ],
        [
          "Sibling"
        ],
        [
          "Labels (device)"
        ],
        [
          "Muscle Rigidity"
        ],
        [
          "Hypoplasia"
        ],
        [
          "Intelligence"
        ],
        [
          "Pyramidal tract signs"
        ],
        [
          "Congenital anomaly of central nervous system"
        ],
        [
          "Myelin"
        ],
        [
          "Manifest"
        ],
        [
          "Cerebral hemisphere structure (body structure)"
        ],
        [
          "Dietary Sulfur"
        ],
        [
          "Cerebellum"
        ],
        [
          "Neuromuscular"
        ],
        [
          "Articular system"
        ],
        [
          "Dysplasia"
        ],
        [
          "Autosomal recessive hereditary disorder"
        ],
        [
          "Hereditary"
        ],
        [
          "Decreased fertility"
        ],
        [
          "Hair growth"
        ],
        [
          "Abnormalities of the hair"
        ],
        [
          "Abnormality"
        ],
        [
          "Low Birth Weights"
        ],
        [
          "definition - ActMoodCompletionTrack"
        ],
        [
          "Definition"
        ],
        [
          "Adverse Event Associated with Syndromes"
        ],
        [
          "parent"
        ],
        [
          "Subcutaneous Fat"
        ],
        [
          "Heterogeneity"
        ],
        [
          "Skin of part of limb"
        ],
        [
          "Maturation defect"
        ],
        [
          "Visual evoked cortical potential"
        ],
        [
          "Lacking"
        ],
        [
          "Original"
        ],
        [
          "White matter"
        ],
        [
          "Feature"
        ],
        [
          "Image Feature"
        ],
        [
          "Classification"
        ],
        [
          "Example"
        ],
        [
          "Increased susceptibility to infections"
        ],
        [
          "Organ"
        ],
        [
          "deficiency aspects"
        ],
        [
          "mental development"
        ],
        [
          "Prolonged"
        ],
        [
          "Biological Evolution"
        ],
        [
          "Numerous"
        ],
        [
          "Impaired"
        ],
        [
          "Abnormal"
        ],
        [
          "clinical aspects"
        ],
        [
          "growth aspects"
        ],
        [
          "development aspects"
        ],
        [
          "Magnetic Resonance Imaging"
        ]
      ],
      "id": "53358cd2d6d3ac6a3400004e",
      "ideal_answer": "For example, the brittle hair due to sulphur deficiency (trichothiodystrophy) is nowadays regarded as genetically heterogeneous; three different syndromes can be distinguished: BIDS syndrome, Tay syndrome, and PIBIDS syndrome. TTD is part of a more broadly defined group of diseases identified as IBIDS (ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature). Tay-syndrome is a rare monogen-inherited ektodermal dysplastic syndrome with ichtyosis, fragility of the hair and physical and mental retardation. Other features of this syndrome are low birth weight, short stature, mental retardation, delayed neuromuscular development and other CNS anomalies, dysplasia of nails, hypoplasia of subcutaneous fatty tissue, prematurely aged facial appearance, hypogonadism, cataracts, osteosclerosis, dysphonia, and increased susceptibility to infections. We report a case of trichothiodystrophy initially classified as Tay syndrome that based on clinical features, complementary exams as well as on the disease evolution was labelled as PIBIDS syndrome. In Tay syndrome, the trichothiodystrophy is accompanied by congenital ichthyosis, short stature, delayed physical and mental development and pyramidal tract signs with increase in muscular tone and brisk tendon reflexes. The Tay syndrome is a distinct type of congenital ichthyosis characterized by a peculiar anomaly of hair growth which has been termed trichothiodystrophy. "
    },
    {
      "exact_answer": "yes",
      "id": "53359338d6d3ac6a3400004f",
      "ideal_answer": "Vortioxetine received its first global approval for MDD in the USA in September 2013 and regulatory approval for its use in this indication in the EU (where it has received a positive opinion) and Canada is awaited. The multimodal compounds vortioxetine and vilazodone are examples of this approach with diverse mechanisms, and their different clinical effects will provide valuable insights into serotonergic modulation of glutamate transmission for the potential treatment of depression and associated cognitive dysfunction. Novel drugs in development include those that combine multiple simultaneous pharmacologic mechanisms in addition to SERT inhibition within the same molecule, such as vilazodone (combining 5HT1A partial agonism with SERT inhibition), triple reuptake inhibitors (combining norepinephrine and dopamine reuptake inhibition with SERT inhibition), and vortioxetine, a multimodal antidepressant combining actions at the G protein receptor mode (5HT1A and 5HT1B partial agonism and 5HT7 antagonism), at the ion channel mode (5HT3 antagonism) as well as the neurotransmitter transporter mode (SERT inhibition). Vortioxetine is a multi-modal antidepressant that functions as a human 5-HT3A and 5-HT7 receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist, and inhibitor of the serotonin transporter. "
    },
    {
      "exact_answer": "yes",
      "id": "5335b373d6d3ac6a34000050",
      "ideal_answer": "This meta-analysis indicates that ospemifene to be an effective and safe treatment for dyspareunia associated with postmenopausal vulvar and vaginal atrophy. The aim of this work was to study the role of ospemifene, a novel selective estrogen receptor modulator, in the treatment of vulvar and vaginal atrophy in postmenopausal women with moderate to severe dyspareunia and physiological vaginal changes. In conclusion, ospemifene is a SERM with a unique estrogen agonist/antagonist tissue profile that was recently approved in the US for the treatment of dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women. To characterize the pharmacokinetics of the oral, non-estrogen agent ospemifene, an estrogen agonist/antagonist with tissue-selective effects (also called a selective estrogen receptor modulator) that was recently approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women. SERMs with positive vaginal effects (such as improvement in the vaginal maturation index, reduced vaginal pH, and improvement in the signs and symptoms of VVA) on postmenopausal symptomatic women include lasofoxifene (clinical development on hold) and ospemifene, which was recently approved for the treatment of VVA-related dyspareunia, with a class effect warning of potential venous thrombosis risk. "
    },
    {
      "exact_answer": [
        [
          "canagliflozin"
        ],
        [
          "dapagliflozin"
        ],
        [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        [
          "empagliflozin"
        ],
        [
          "Diabetes Mellitus, Non-Insulin-Dependent"
        ]
      ],
      "id": "5335c7f2d6d3ac6a34000051",
      "ideal_answer": "Currently dapagliflozin, one of the three most advanced SGLT2 inhibitors in the development (along with canagliflozin and empagliflozin), is already in the market in few European countries and canagliflozin has been approved from the Food and Drug Administration (FDA) in US. This report reviews the potentially beneficial effects of SGLT2 inhibitors in type 2 diabetes mellitus, specifically focusing on canagliflozin, the only SGLT2 inhibitor approved for use in the United States. During the past year, two SGLT2 inhibitors, canagliflozin and dapagliflozin, have been approved for the treatment of type 2 diabetes. Canagliflozin (Invokana™), an oral selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, is under global development with Mitsubishi Tanabe Pharma and Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, for the treatment of type 2 diabetes mellitus. Canagliflozin is an orally administered sodium glucose cotransporter 2 inhibitor proposed for the treatment of type 2 diabetes. Canagliflozin is the first SGLT2 inhibitor to be approved in the USA and is under regulatory review in the EU. Canagliflozin reduces postprandial plasma glucose and insulin by increasing UGE (via renal SGLT2 inhibition) and delaying RaO, likely due to intestinal SGLT1 inhibition. Sodium glucose co-transporter 2 (SGLT2) inhibition with canagliflozin in type 2 diabetes mellitus. "
    },
    {
      "exact_answer": [
        [
          "Macitentan"
        ],
        [
          "Receptor, Endothelin A"
        ],
        [
          "Endothelin receptor antagonist"
        ],
        [
          "Endothelin"
        ],
        [
          "Dual - RoleCode"
        ],
        [
          "riociguat"
        ],
        [
          "Tissue Specimen Code"
        ],
        [
          "receptor"
        ],
        [
          "bosentan"
        ],
        [
          "Antagonist muscle action"
        ],
        [
          "soluble guanylyl cyclase"
        ],
        [
          "Target"
        ],
        [
          "Epoprostenol"
        ],
        [
          "Negation"
        ],
        [
          "Adoptive Immunotherapy"
        ],
        [
          "Idiopathic pulmonary hypertension"
        ],
        [
          "Per Billion"
        ],
        [
          "ambrisentan"
        ],
        [
          "imatinib"
        ],
        [
          "Oral"
        ],
        [
          "N not otherwise specified Antibody"
        ],
        [
          "Integer +5"
        ],
        [
          "Property (attribute)"
        ],
        [
          "EDNRB gene"
        ],
        [
          "Contraction (finding)"
        ],
        [
          "Investigates"
        ],
        [
          "Prostacycline [EPC]"
        ],
        [
          "Active"
        ],
        [
          "antagonists"
        ],
        [
          "Idiopathic Pulmonary Fibrosis"
        ],
        [
          "Receptor Protein-Tyrosine Kinases"
        ],
        [
          "literary novel"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Preposition For"
        ],
        [
          "Potential"
        ],
        [
          "Induce (action)"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Bed Status - Isolated"
        ],
        [
          "Continuance of life"
        ],
        [
          "Long-Term Synaptic Depression"
        ],
        [
          "Tolerability Study"
        ],
        [
          "EDNRA gene"
        ],
        [
          "Efficacy Study"
        ],
        [
          "Rattus norvegicus"
        ],
        [
          "Stimulator"
        ],
        [
          "Superoxide Dismutase"
        ],
        [
          "Drug Kinetics"
        ],
        [
          "Endothelin-1"
        ],
        [
          "Pharmacologic Substance"
        ],
        [
          "Comparison"
        ],
        [
          "tempol"
        ],
        [
          "BQ 788"
        ],
        [
          "Nitric Oxide"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Sustained"
        ],
        [
          "Analog"
        ],
        [
          "Integer +2"
        ],
        [
          "Act Class - investigation"
        ],
        [
          "Prostaglandins"
        ],
        [
          "endothelin A receptor binding"
        ],
        [
          "Receptor, Endothelin B"
        ],
        [
          "Endothelin Receptor Antagonists [MoA]"
        ],
        [
          "nintedanib"
        ],
        [
          "BQ 123"
        ],
        [
          "Changing"
        ],
        [
          "Safety Study"
        ],
        [
          "Rifampin"
        ],
        [
          "Biologic Development"
        ],
        [
          "Various patch test substance"
        ],
        [
          "New medications"
        ],
        [
          "Hypertensive (finding)"
        ],
        [
          "Metabolite"
        ],
        [
          "tadalafil"
        ],
        [
          "Cyclosporine"
        ],
        [
          "Abnormally high"
        ],
        [
          "ERAS gene"
        ],
        [
          "Endothelin Receptor"
        ],
        [
          "Healthy Volunteers"
        ],
        [
          "Iloprost"
        ],
        [
          "Peptides"
        ],
        [
          "sildenafil"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Ketoconazole"
        ],
        [
          "Numerous"
        ],
        [
          "compound 17"
        ],
        [
          "development aspects"
        ],
        [
          "Body tissue"
        ],
        [
          "Diabetes Mellitus, Non-Insulin-Dependent"
        ],
        [
          "2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide"
        ],
        [
          "chronic"
        ],
        [
          "pharmacodynamic aspects"
        ],
        [
          "Lung"
        ],
        [
          "Study"
        ],
        [
          "Paclitaxel"
        ],
        [
          "Pathway (interactions)"
        ],
        [
          "Sequencing - Ascending"
        ],
        [
          "Conclude Resin"
        ],
        [
          "Affinity"
        ],
        [
          "Phase 3"
        ],
        [
          "Mortality Vital Statistics"
        ]
      ],
      "id": "5335d4e8d6d3ac6a34000053",
      "ideal_answer": "Given that the newest PAH drugs include a receptor tyrosine kinase antagonist (imatinib), a soluble guanylate cyclase stimulator (riociguat), an oral analog of prostacyclin (selexipag), and a tissue targeting ERA (macitentan) determination of appropriate combinations for various etiologies and clinical stages is urgently required. imatinib); soluble guanylate cyclase stimulators (riociguat); an oral analog of prostacyclin (selexipag); and a tissue targeting endothelin receptor antagonist (macitentan). Macitentan, because of its ability to target the tissues and to block both ET(A) and ET(B) receptors, is emerging as a new agent to treat cardiovascular disorders associated with chronic tissue ET system activation. Macitentan is a potent, orally active, non-peptide antagonist of endothelin receptors with tissue-targeting properties, currently undergoing clinical development for the treatment of pulmonary arterial hypertension. Macitentan (ACT-064992), under development by Actelion Ltd in collaboration with Japanese licensee Nippon Shinyaku Co Ltd, is an orally active, non-peptide dual endothelin (ET)(A) and ET(B) receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). "
    },
    {
      "exact_answer": "yes",
      "id": "53372b66d6d3ac6a34000057",
      "ideal_answer": "fficient cellular fractionation improves RNA sequencing analysis of mature and nascent transcripts from human tissues. Here we show that RNA-seq can also be used for studying nascent RNAs undergoing transcription. Here, we utilize nascent RNA sequencing to document dosage compensation during transcriptional elongation. "
    },
    {
      "id": "533ada5efd9a95ea0d000001",
      "ideal_answer": "lncRNAs in central nervous system (CNS) development and neurodegenerative diseases, including Alzheimer\u0027s disease (AD). the genotype of this SNP shows different distribution in normal elders, mild cognitive impairment, and Alzheimer disease subjects, suggesting that this lincRNA may have a role in physiology and pathophysiology of human brain. non-coding (nc) RNA (hereafter referred to as 51A) that maps in antisense configuration to intron 1 of the SORL1 gene. In the MTG of AD patients, the mature GDNF peptide was down-regulated; however, the transcript of GDNF isoform from human exon 2 was up-regulated. The findings of novel GDNF and GDNFOS isoforms and differences in tissue expression patterns dysregulated in AD brains. (lncRNA) within mRNA sequences of Alzheimer\u0027s disease genes, namely, APP, APOE, PSEN1, and PSEN2. novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. novel non-coding (nc) RNA (named 17A) RNA polymerase (pol) III-dependent embedded in the human G-protein-coupled receptor 51 gene (GPR51, GABA B2 receptor). 17A is expressed in human brain, and we report that it is upregulated in cerebral tissues derived from Alzheimer disease patients. lncRNAs in Alzheimer\u0027s disease mRNA sequences. "
    },
    {
      "exact_answer": [
        [
          "YAP1 gene"
        ],
        [
          "Yorkshire terrier"
        ],
        [
          "Orthologous Gene"
        ],
        [
          "YAP1 protein, human"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Vertebrates"
        ],
        [
          "Drosophila \u003cfruit fly, genus\u003e"
        ]
      ],
      "id": "533c2a55c45e133714000003",
      "ideal_answer": "YAP1, the ortholog of Drosophila Yorkie. Yorkie ortholog YAP. Yorkie ortholog, Yap1. human ortholog of Yorkie, YAP. Yorkie homolog YAP. Yki (YAP/TAZ in vertebrates. "
    },
    {
      "exact_answer": [
        [
          "CYLD gene"
        ],
        [
          "Ancell-Spiegler cylindromas"
        ],
        [
          "SLC25A32 gene"
        ],
        [
          "Introns"
        ],
        [
          "Mutation"
        ],
        [
          "Germ-Line Mutation"
        ],
        [
          "Trichoepithelioma"
        ],
        [
          "Familial multiple trichoepitheliomata"
        ],
        [
          "Germline Mutation Abnormality"
        ],
        [
          "maspin"
        ],
        [
          "Identified"
        ],
        [
          "Brooke-Spiegler syndrome"
        ],
        [
          "16q12"
        ],
        [
          "Slovaks"
        ],
        [
          "Heterozygote"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Gene Mutation"
        ],
        [
          "Tumor Suppressor Genes"
        ],
        [
          "Depth"
        ],
        [
          "Eccrine spiradenoma"
        ],
        [
          "Expression procedure"
        ],
        [
          "Family"
        ],
        [
          "Involvement with"
        ],
        [
          "Neoplasm"
        ],
        [
          "Genes, vif"
        ],
        [
          "Chromosomes"
        ],
        [
          "Neoplasm of skin with adnexal differentiation"
        ],
        [
          "Mimic brand of tebufenozide"
        ],
        [
          "Various patch test substance"
        ],
        [
          "Novel Mutation"
        ],
        [
          "Q13"
        ],
        [
          "Generic Role"
        ],
        [
          "Belarus"
        ],
        [
          "Patients"
        ],
        [
          "Adenoid Cystic Carcinoma"
        ],
        [
          "Syndrome"
        ],
        [
          "Somatic mutation"
        ],
        [
          "Carrying"
        ],
        [
          "Scientific Study"
        ],
        [
          "Phenotype"
        ],
        [
          "Tumorigenicity"
        ],
        [
          "Gram per Deciliter"
        ],
        [
          "Case (situation)"
        ],
        [
          "development aspects"
        ],
        [
          "Science of Etiology"
        ],
        [
          "Mutation, Nonsense"
        ],
        [
          "Associated with"
        ],
        [
          "Appendage"
        ],
        [
          "Exons"
        ],
        [
          "Race - Taiwanese"
        ],
        [
          "Cytogenetics"
        ],
        [
          "MAL gene"
        ],
        [
          "Evidence of"
        ],
        [
          "Interphase"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Providing (action)"
        ],
        [
          "Aspartic Acid"
        ],
        [
          "Familial"
        ],
        [
          "Etiology aspects"
        ],
        [
          "Locus"
        ],
        [
          "Autosomal dominant inheritance"
        ],
        [
          "Persons"
        ],
        [
          "Integer +2"
        ],
        [
          "Benign neoplasm of skin"
        ],
        [
          "RNA Splicing"
        ],
        [
          "Previous"
        ],
        [
          "Experimental Result"
        ],
        [
          "Leading"
        ],
        [
          "Functional Map"
        ],
        [
          "Eccrine dermal cylindroma"
        ],
        [
          "Observed"
        ],
        [
          "Individual"
        ],
        [
          "Histopathology"
        ],
        [
          "Report (document)"
        ],
        [
          "Characterization"
        ],
        [
          "Sequence Analysis"
        ],
        [
          "Numerous"
        ],
        [
          "Genetic"
        ],
        [
          "Primary operation"
        ],
        [
          "Tellurium"
        ],
        [
          "Clinical"
        ],
        [
          "Mutation Abnormality"
        ],
        [
          "Responsible to"
        ],
        [
          "Chinese Language"
        ],
        [
          "Large"
        ],
        [
          "Patterns"
        ],
        [
          "Face"
        ],
        [
          "Frameshift Mutation function"
        ],
        [
          "Genes"
        ],
        [
          "MT1L gene"
        ],
        [
          "Decreased"
        ],
        [
          "PNPT1 gene"
        ],
        [
          "Diagnosis Study"
        ],
        [
          "16q21"
        ],
        [
          "9q22.3"
        ],
        [
          "Cell of Claudius"
        ],
        [
          "9q22"
        ],
        [
          "Journalist"
        ],
        [
          "Nodulus cerebelli"
        ]
      ],
      "id": "533c3af6c45e13371400000d",
      "ideal_answer": "we demonstrate that the expression in tumorigenic epidermal cells of a catalytically inactive form of CYLD (CYLD(C/S)) that mimics the identified mutations of cyld in human tumors and competes with the endogenous CYLD results in enhanced cell proliferation and inhibition of apoptosi. In addition, we have characterized Maspin downregulation in cylindromas, trichoepitheliomas, and spiradenomas carrying functional inactivating mutations of CYLD, also providing an evidence of the correlation between impaired CYLD function and Maspin decreased expression in vivo in human tumors. In contrast with previous studies showing the development of benign tumors by mutations in the CYLD gene, here we provide evidence that the occurrence of mutations in the CYLD gene in tumorigenic epidermal cells (carrying previous mutations) increases the aggressiveness of carcinomas, mainly through enhancement of the expression of angiogenic factors, having therefore a key role in epidermal cancer malignancy. Although some early studies suggested a role for the PTCH gene on chromosome 9q22.3 in the etiopathogenesis of MFT, recent studies of occasional patients with the MFT clinical phenotype identified mutations in the CYLD gene on chromosome 16q12-q13, a gene responsible for BSS. "
    },
    {
      "exact_answer": "yes",
      "id": "533eb89fc45e133714000012",
      "ideal_answer": "MDA468 breast tumor cell lines were incubated with a high amifostine concentration (10 m M) to overcome the natural resistance of cancer cells to influx of the non-hydrolyzed WR-2721, and the HIF1 alpha protein levels were determined by Western blot analysis. Since it is doubtful whether dephosphorylation of amifostine to the active metabolite WR-1065 occurs within tumoral tissues (an acidic environment that lacks vascular alkaline phosphatase activity), intracellular hypoxia and upregulation of HIF1 alpha represents an additional, normal tissue-specific, amifostine cytoprotective pathway. We demonstrated that the treatment of several human cancer cell lines with therapeutical doses of WR-1065 led to a strong induction of different VEGF-A mRNA isoforms independently of HIF-1alpha. The glucose and oxygen levels in the peripheral blood of patients receiving 1000 mg amifostine were determined at various time-points in order to investigate the metabolic changes induced by amifostine. In accord with previously reported studies, high levels of the hypoxia regulated proteins HIF1alpha and CA9 in HNC predict resistance to platinum based radio-chemotherapy. e investigated the involvement of hypoxia-regulated proteins (Hypoxia inducible factors HIF1alpha, HIF2alpha and carbonic anhydrase CA9) in HNC resistance to accelerated and hypofractionated radiotherapy. "
    },
    {
      "id": "533eba45c45e133714000014",
      "ideal_answer": "Amifostine (WR-2721, delivered as Ethyol) is a phosphorylated aminothiol compound clinically used in addition to cis-platinum to reduce the toxic side effects of therapeutic treatment on normal cells without reducing their efficacy on tumour cells. Amifostine as inactive prodrug is primarily metabolized at the tissue site by membrane alkaline phosphatase, which is highly active in the cell membranes of normal endothelial cells and biliary tree cells but not in the cell membranes and neovascular capillaries of tumor. An inactive prodrug, amifostine is converted to an active thiol by dephosphorylation by alkaline phosphatase in the normal endothelium. However, amifostine has also been described as a potent hypoxia-mimetic compound and as a strong p53 inducer; both effects are known to potently modulate vascular endothelial growth factor (VEGF-A) expression. Fractionation but not amifostine was protective for hypoxia-induced vascular endothelial growth factor production (used as a surrogate marker of normal osteoblast function). Radioprotective modalities such as dose fractionation and pharmacologic agents such as amifostine have been used to protect bone and other types of normal tissue from the damaging effects of ionizing radiation without significantly impacting tumor kill. "
    },
    {
      "id": "5341d15dc45e133714000018",
      "ideal_answer": "autophagy, a process in which de novo formed membrane enclosed vesicles engulf and consume cellular components. As a general definition, autophagy encompasses a range of processes in which the cell degrades parts of itself within the lysosome (or the analogous organelle, the vacuole, in yeast and plants), followed by the release and reuse of the breakdown products. definition of autophagy is the following: all processes in which intracellular material is degraded within the lysosome/vacuole and where the macromolecular constituents are recycled. Autophagic PCD in animals is defined as being accompanied by an increase in the number of autophagosomes, autolysosomes, and small lytic vacuoles produced by autolysosomes. utophagy is the endogenous, tightly regulated cellular \"housekeeping\" process responsible for the degradation of damaged and dysfunctional cellular organelles and protein aggregates. utophagy and senescence share a number of characteristics, which suggests that both responses could serve to collaterally protect the cell from the toxicity of external stress such as radiation and chemotherapy and internal forms of stress such as telomere shortening and oncogene activation. utophagy is a catabolic trafficking pathway for bulk destruction and turnover of long-lived proteins and organelles via regulated lysosomal degradation. "
    },
    {
      "id": "534289851eccfd0633000001",
      "ideal_answer": ". Amifostine alone is inactive chemically, but active metabolite amifostine WR-1065 has been assumed to protect the healthy tissues during antineoplastic therapy by bounding of anticancer drug, causing their detoxification and/or eliminating the free radicals generated during radiation and cytostatic therapy. Amifostine (Ethyoltrade mark, Alza Pharmaceuticals) is an inorganic thiophosphate cytoprotective agent known chemically as ethanethiol, 2-[3- aminopropyl)amino]dihydrogen phosphate. It is a prodrug of free thiol (WR-1065) that may act as a scavenger of free radicals generated in tissues exposed to cytotoxic drugs and binds to reactive metabolites of such drugs. Moreover, amifostine prevented benzene-induced bone marrow and spleen cell apoptosis and rescinded the inhibition of cell proliferation induced by benzene exposure. CYP), a commonly prescribed chemotherapy drug, has multiple adverse side effects including alteration of taste. This is the first report focusing on amifostine related adverse effects leading to discontinuation of amifostine treatment. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro. An increasing number of human clinical trials have been conducted that define the toxicity profile and efficacy of radioprotection by amifostine when used during fractionated radiation therapy. "
    },
    {
      "exact_answer": [
        [
          "RNA Polymerase II"
        ],
        [
          "Serine"
        ],
        [
          "Paused"
        ],
        [
          "Protein phosphorylation"
        ],
        [
          "Promoter"
        ]
      ],
      "id": "5343bdd6aeec6fbd07000001",
      "ideal_answer": "the promoter-paused Pol II shows Ser5 but not Ser2 phosphorylation. The carboxy-terminal domain of the paused polymerase large subunit is hyperphosphorylated on serine 5, and phosphorylation of serine 2 is first detected here. For genes containing a 5\u0027 paused polymerase, passage of the paused RNA polymerase into an elongationally competent mode in vivo coincides with phosphorylation of the CTD. increase levels of serine-5 phosphorylated RNA polymerase II in the mutation target region, consistent with an effect on transcriptional elongation/pausing. Pause release depends on Cdk9-cyclin T1 (P-TEFb); Cdk7 is also required for Cdk9-activating phosphorylation and Cdk9-dependent downstream events--Pol II C-terminal domain Ser2 phosphorylation. the promoter-paused form of Pol II (Pol IIo(ser5). pol-II accumulated in the 5\u0027-region of the gene, which indicated postinitiation pausing. pol-II binding, 5\u0027-accumulation, C-terminal domain Ser-5 and Ser-2 phosphorylation. Ser-5 phosphorylation of Pol II is concentrated near the promoter. "
    },
    {
      "exact_answer": [
        [
          "Selenoprotein P"
        ],
        [
          "Superkingdom (taxonomic category)"
        ],
        [
          "Selenoproteins"
        ],
        [
          "Selenocysteine"
        ],
        [
          "Containing (qualifier)"
        ]
      ],
      "id": "5343caffaeec6fbd07000002",
      "ideal_answer": "The larger N-terminal domain contains 1 selenocysteine residue in a redox motif and the smaller C-terminal domain contains the other 9 selenocysteines. Human selenoprotein P (HSelP) is unique protein that contains 10 selenocysteines encoded by 10 inframe UGA. selenoprotein P genes encode multiple UGAs and two SECIS elements. human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines. rat and human selenoprotein P cDNA but contained 12 rather than 10 TGAs. Selenoprotein P is unique in that its mRNA encodes 10-12 selenocysteine residues. Sepp1) is a secreted protein that is made up of 2 domains. selenoprotein P and several other selenoproteins are known to contain multiple selenocysteines. The deduced polypeptide sequence comprises 380 residues including ten selenocysteines. selenoprotein P-like protein containing 12 selenocysteines. selenoprotein-P. SeP) is an extracellular glycoprotein with 8-10 selenocysteines per molecule. "
    },
    {
      "exact_answer": [
        [
          "NF1 gene"
        ],
        [
          "NFI Transcription Factors"
        ],
        [
          "Neurofibromatosis 1"
        ],
        [
          "Neurofibromatosis Type 1 Protein"
        ],
        [
          "shared attribute"
        ]
      ],
      "id": "5343fc1aaeec6fbd07000003",
      "ideal_answer": "The NF1 gene, mutated in NF1, is also commonly mutated in sporadic glioblastoma multiforme (GBM). genes mutated in these two disorders encode tumor suppressor proteins, termed neurofibromin (NF1). The gene responsible for this disorder, NF1, encodes neurofibromin,. type 1 (NF1) is caused by deletions, insertions, translocations, and point mutations in the NF1 gene. type 1 (NF1) is a hereditary disorder caused by mutations in the NF1 gene. Neurofibromatosis type 1 (NF1) is a common disorder of dysregulated tissue growth secondary to mutations in the tumor suppressor gene NF1. type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene. type 1 (NF1) is an autosomal dominant genetic disorder affecting one in 3,500 individuals. ysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1. Individuals with NF1 harbor 1 mutated NF1 allele. An NF1 gene was identified as a gene whose loss of function causes an onset of human disorder, neurofibromatosis type I. "
    },
    {
      "exact_answer": [
        [
          "MALAT1 gene"
        ],
        [
          "RNA, Long Untranslated"
        ],
        [
          "Upward"
        ],
        [
          "Mus"
        ],
        [
          "thymosin beta(4)"
        ]
      ],
      "id": "53440d2caeec6fbd07000004",
      "ideal_answer": "lncRNA MALAT-1 expression is upregulated in some tumors. metastasis-associated lung adenocarcinoma transcript 1, MALAT1, is a long non-coding RNA (lncRNA) that has been discovered as a marker for lung cancer metastasis. (MALAT1), a long non-coding RNA (lncRNA), is up-regulated in many solid tumors and associated with cancer metastasis and recurrence. Several of the identified genes (eIF4A1, thymosin beta4 and a novel transcript named MALAT-1) were demonstrated to be significantly associated with metastasis in NSCLC patients. Quantitative analyses indicated a 6-7-fold increased RNA level in HCCs versus uninvolved liver,. Genome-wide profiling revealed that MALAT-1 and prostate cancer gene 3 (PCA3) are overexpressed in PCa tissues. After suppression subtractive hybridization and differential screening, we detected the metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) gene as one of the major genes upregulated in ESS. MALAT-1 was up-regulated in human prostate cancer tissues and cell lines. Σ RNA is a class of conserved large non-coding RNAs (murine Hepcarcin; human MALAT-1) up-regulated in carcinomas. The gene appears to be the murine ortholog of the human alpha gene, that is, MALAT-1. a novel non-coding RNA (MALAT-1) to be expressed at significantly higher levels in stage-I and stage-II NSCLC primary tumours that subsequently metastasised. "
    },
    {
      "exact_answer": [
        [
          "Mucopolysaccharidosis II"
        ],
        [
          "X- linked recessive"
        ],
        [
          "Disease"
        ],
        [
          "X Chromosome"
        ],
        [
          "X-linked inheritance"
        ]
      ],
      "id": "5344155faeec6fbd07000005",
      "ideal_answer": "ysosomal diseases (LD) are inherited as autosomal recessive traits, but two important conditions have X-linked inheritance: Fabry disease and Mucopolysaccharidosis II (MPS II). unter disease, Mucopolysaccharidosis type II, is an X-linked recessive lysosomal storage disorder. unter syndrome is an X-linked recessive disorder. unter disease, an X-linked recessive lethal. X-linked disease. Hunter syndrome in females. X chromosome heterozygosity and confirmed the paternal origin of one of the X chromosomes. Hunter\u0027s disease in a female with an X-chromosome deletion. Chromosome studies on the patient revealed a partial deletion of the long arm of one X-chromosome,. "
    },
    {
      "exact_answer": "yes",
      "id": "5344194daeec6fbd07000006",
      "ideal_answer": "histone H2B-specific deubiquitinase and demonstrate that H2B deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons. 2B ubiquitylation is part of chromatin architecture that marks exon-intron structure. H2B monoubiquitylation (H2BK123ub1) marks introns in Saccharomyces cerevisiae. H2B ubiquitination by facilitating splicing. pre-mRNA splicing plays a critical role in histone H2B ubiquitination. unanticipated functional link between histone H2B ubiquitination and pre-mRNA splicing. "
    },
    {
      "exact_answer": [
        [
          "Haspin"
        ],
        [
          "Threonine"
        ],
        [
          "Histone H3.3"
        ],
        [
          "Phosphotransferases"
        ],
        [
          "Histone H3"
        ]
      ],
      "id": "53442023aeec6fbd07000007",
      "ideal_answer": "Haspin localizes predominantly to chromosomes and phosphorylates histone H3 at threonine-3 during mitosis. During mitosis haspin is phosphorylated, associates with the chromosomes, centrosomes and spindle, and is responsible for phosphorylation of histone H3 at threonine-3. haspin/Gsg2 plays an important role in mitosis, where it specifically phosphorylates Thr-3 in histone H3 (H3T3. aspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis. phosphorylating Thr3 of histone H3, Haspin promotes centromeric recruitment of the chromosome passenger complex (CPC) during mitosis. aspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis. histone H3 specifically when it is phosphorylated at threonine 3, a mark that is placed by the mitotic kinase, haspin. protein kinase Haspin-mediated spreading of H3T3ph. phosphorylation of histone H3 threonine 3 (H3-pT3) mediated by Haspin. phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin. istone H3 Thr-3 phosphorylation by Haspin. Haspin/Gsg2 is a histone H3 threonine-3 kinase. haspin, a member of a distinctive group of protein kinases present in diverse eukaryotes, phosphorylates H3 at Thr 3. aspin is an atypical protein kinase that in several organisms phosphorylates histone H3Thr3. histone H3 that is phosphorylated at T3 (H3T3ph) by Aurora B-stimulated Haspin. Haspin-dependent histone H3 phosphorylatio. "
    },
    {
      "id": "53442472aeec6fbd07000008",
      "ideal_answer": "high expression of ephrin-B2 is a strong predictor of short-term survival and that ephrin-B2 plays a critical role in glioma invasion rendering this signaling pathway as a potential therapeutic target. deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases. EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive therapeutic target for the treatment of brain tumor. ccumulating evidence indicates that Eph and ephrins are frequently overexpressed in different tumor types including GBM. migrating glioblastoma cells overexpress EphB2 in vitro and in vivo; glioma migration and invasion are promoted by activation of EphB2 or inhibited by blocking EphB2. gene expression of Eph receptors and ephrins in benign human tissues and cancers. crosstalk between Eph and integrin signalling pathways at the membrane protrusions and in the migration of brain cancer cells. phB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. p-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma. phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. "
    },
    {
      "exact_answer": [
        [
          "ERAP2 gene"
        ],
        [
          "Peptide Hydrolases"
        ],
        [
          "Endoplasmic Reticulum"
        ],
        [
          "ERAP1 protein, human"
        ],
        [
          "CEBPB wt Allele"
        ]
      ],
      "id": "53442ca9aeec6fbd0700000b",
      "ideal_answer": "ERAP2 is a proteolytic enzyme set in the endoplasmic reticulum (ER). They are categorized as a unique class of proteases based on their subcellular localization on the luminal side of the endoplasmic reticulum. both A-LAP and L-RAP are retained in the endoplasmic reticulum. The human endoplasmic reticulum aminopeptidase (ERAP) 1 and 2 proteins. endoplasmic reticulum aminopeptidase 2 (ERAP2). "
    },
    {
      "exact_answer": "yes",
      "id": "53443b13aeec6fbd0700000e",
      "ideal_answer": "This review will describe pre-clinical and clinical data of four major classes of TGF-β inhibitor, namely i) ligand traps, ii) antisense oligonucleotides, iii) receptor kinase inhibitors and iv) peptide aptamers. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. . The target of one inhibitor peptide, Pep80, identified in this screen was determined to be Snapin, a protein associated with the soluble N-ethyl maleimide sensitive factor adaptor protein receptor (SNARE) complex that is critical for calcium-dependent exocytosis during neurotransmission. he fusion peptide, TA aptamer, was observed within PC12 cytoplasm and maintained both Abeta-binding ability and antioxygenic property similar to TRX. Peptide aptamers are peptides constrained and presented by a scaffold protein that are used to study protein function in cells. Peptide aptamer mimicking RAD51-binding domain of BRCA2 inhibits DNA damage repair and survival in Trypanosoma brucei. Intracellular expression of the DRD-binding peptide aptamer specifically suppressed receptor-mediated extrinsic apoptosis but not intrinsic pathway, which was recapitulated by the antisense oligonucleotides for FLASH. Here we have used a genetic screen in yeast to select in vivo peptides coupled to thioredoxin, called aptamers, that could inhibit GEFD2 activity. "
    },
    {
      "exact_answer": "yes",
      "id": "53455e0caeec6fbd0700000f",
      "ideal_answer": "analysis of the role of JNK signaling pathway in regulating cell proliferation and apoptosis of rat liver regeneration. stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathway. genetic inactivation of the JNK pathway results in impaired proliferation of fetal hepatoblasts in vitro and defective adult liver regeneration in vivo. add45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. Although mechanical stress has been implicated in hepatic cirrhosis and liver regeneration following hepatectomy, the signaling pathway(s) that may be activated in hepatocytes in response to mechanical stress have not been determined. arsenite induced apoptosis in the hepatocytes in vivo, through the enhancement of the activation of JNK and p38 MAPK caused by partial hepatectomy. induction of CD40-mediated cholangiocyte apoptosis requires JAK2-mediated phosphorylation of STAT3 as well as sustained JNK1/2, ERK1/2 activation. Loss of macroautophagy led to overactivation of the c-Jun N-terminal kinase (JNK)/c-Jun signaling pathway that induced cell death. Mice lacking c-jun in the liver display impaired regeneration after partial hepatectomy (PH). JNK, ERK and JAK2 inhibitors partially abrogated apoptosis and when used in combination reduced it to basal levels. "
    },
    {
      "id": "53482bfcaeec6fbd07000010",
      "ideal_answer": "the UPS2 proteomic dynamic range standard introduced by The Association of Biomolecular Resource Facilities Proteomics Standards Research Group in 2006). Universal Proteomics Standard sample with a dynamic range of 5 orders of magnitude (UPS2). "
    },
    {
      "exact_answer": [
        [
          "Base - General Qualifier"
        ],
        [
          "Quantitation"
        ],
        [
          "Absolute"
        ],
        [
          "With intensity"
        ],
        [
          "% index"
        ]
      ],
      "id": "5348307daeec6fbd07000011",
      "ideal_answer": "intensity-based absolute quantification (iBAQ). Intensity-Based Absolute Quantification Index,. "
    },
    {
      "exact_answer": [
        [
          "HEPACAM gene"
        ],
        [
          "methylate"
        ],
        [
          "Promoter"
        ],
        [
          "Malignant neoplasm of urinary bladder"
        ],
        [
          "CpG Islands"
        ],
        [
          "Exons"
        ],
        [
          "RAB40B wt Allele"
        ],
        [
          "Protein methylation"
        ],
        [
          "CDKN2A gene"
        ],
        [
          "Promoter Regions, Genetic"
        ],
        [
          "Integer +2"
        ],
        [
          "Carcinoma of bladder"
        ],
        [
          "Operator gene"
        ],
        [
          "Expression procedure"
        ],
        [
          "PROC wt Allele"
        ],
        [
          "Negation"
        ],
        [
          "Schistosoma"
        ],
        [
          "Azacitidine"
        ],
        [
          "Urinary Bladder"
        ],
        [
          "Transcript"
        ],
        [
          "RNA, Messenger"
        ],
        [
          "Body tissue"
        ],
        [
          "Cell Adhesion Molecule Gene"
        ],
        [
          "Cells"
        ],
        [
          "Genes"
        ],
        [
          "Hypermethylation"
        ],
        [
          "Involvement with"
        ],
        [
          "Absence (morphologic abnormality)"
        ],
        [
          "Patients"
        ],
        [
          "Superkingdom (taxonomic category)"
        ],
        [
          "TMEFF2 gene"
        ],
        [
          "RASSF1 gene"
        ],
        [
          "Downy hair"
        ],
        [
          "Anabolism"
        ],
        [
          "Aftercare"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Integer +5"
        ],
        [
          "FST gene"
        ],
        [
          "Hyperactive behavior"
        ],
        [
          "A little bit"
        ],
        [
          "Singular"
        ],
        [
          "hypermethylation of CpG island"
        ],
        [
          "coverage - financial contract"
        ],
        [
          "APC gene"
        ],
        [
          "Transitional cell carcinoma of bladder"
        ],
        [
          "P prime"
        ],
        [
          "Firstly"
        ],
        [
          "Hepatocyte"
        ],
        [
          "Supportive assistance"
        ],
        [
          "Stop (Instruction Imperative)"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "DNA, Neoplasm"
        ],
        [
          "Aberrant"
        ],
        [
          "Integral Membrane Proteins"
        ],
        [
          "Stomach"
        ],
        [
          "DNA Methylation"
        ],
        [
          "Upstream"
        ],
        [
          "Reporting"
        ],
        [
          "Cardiac Arrest"
        ],
        [
          "Genes, Suppressor"
        ],
        [
          "epidermal growth factor receptor binding activity"
        ],
        [
          "Tumor-Suppressor Gene Inactivation"
        ],
        [
          "Absent"
        ],
        [
          "cytidylyl-3\u0027-5\u0027-guanosine"
        ],
        [
          "Bladder cells"
        ],
        [
          "Healthy Volunteers"
        ],
        [
          "Colon structure (body structure)"
        ],
        [
          "Adjacent"
        ],
        [
          "regional"
        ],
        [
          "Initiation"
        ],
        [
          "Bilateral"
        ],
        [
          "Benign"
        ],
        [
          "Reverse"
        ],
        [
          "Progressive"
        ],
        [
          "Urinary tract"
        ],
        [
          "Providing (action)"
        ],
        [
          "Contain (action)"
        ],
        [
          "Occurrence"
        ],
        [
          "Abnormal"
        ],
        [
          "Cultured Cell Line"
        ],
        [
          "Tumor cells, malignant"
        ],
        [
          "PREVENT (product)"
        ],
        [
          "Biological Markers"
        ],
        [
          "Respiratory Domain"
        ],
        [
          "Identification (Psychology)"
        ],
        [
          "Liver carcinoma"
        ],
        [
          "Status"
        ],
        [
          "Diagnostic"
        ],
        [
          "Number of sites"
        ],
        [
          "Detection"
        ],
        [
          "Active"
        ],
        [
          "Decreased"
        ],
        [
          "Early Diagnosis"
        ],
        [
          "Evidence of"
        ],
        [
          "Rate"
        ],
        [
          "Model"
        ],
        [
          "Gene Expression"
        ],
        [
          "Function"
        ],
        [
          "Three"
        ],
        [
          "Human cells"
        ]
      ],
      "id": "534ab91eaeec6fbd07000012",
      "ideal_answer": "CpG island in promoter of hepaCAM gene was hyper-methylated both in bladder carcinoma tissues and cell lines (T24 and BIU-87). Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma. the expression of hepaCAM was absent in T24 and BIU-87 cells, and we found that exon 2 of hepaCAM was methylated in the 2 cells. Methylation of the CpG island in the promoter of the p16 gene in human bladder cancer cells did not stop the formation of a transcript initiated 20 kb upstream by the p19 promoter but did prevent the expression of a p16 transcript. Methylated RARβ(2) and APC were significantly higher in bladder cancer patients (62.8%, 59.5%) than benign (16.4%, 5%) but not detected in healthy volunteers (0%) at (P \u003c 0.0001). Abnormal hypermethylation in CpG island of hepaCAM promoter is involved in absence of hepaCAM gene expression when bladder cancer occurs. Thus, methylated RARβ(2) and APC genes might be valuable urinary molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Among the 128 patients with bilharzial bladder cancer, 94 (73.4%) showed methylated RARβ(2) and 86 (67.2%) showed methylated APC. "
    },
    {
      "exact_answer": [
        [
          "HSP90 Heat-Shock Proteins"
        ],
        [
          "Recombinant 70-kD Heat-Shock Protein"
        ],
        [
          "Heat-Shock Proteins 70"
        ],
        [
          "Expression procedure"
        ],
        [
          "Induce (action)"
        ]
      ],
      "id": "534abe8aaeec6fbd07000013",
      "ideal_answer": "HSP90 inhibition was associated with decreased neuroendocrine ErbB and IGF-I receptor expression, decreased Erk and Akt phospho-rylation and the induction of HSP70 expression. Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation. Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro. "
    },
    {
      "exact_answer": [
        [
          "Thyroid Hormones"
        ],
        [
          "Octopamine"
        ],
        [
          "Calcium"
        ],
        [
          "Ketonuria"
        ],
        [
          "Phenethylamine"
        ],
        [
          "tryptamine"
        ],
        [
          "Adoptive Immunotherapy"
        ],
        [
          "heart rate"
        ],
        [
          "Hyperglycemia"
        ],
        [
          "Physiological action"
        ],
        [
          "Body Temperature"
        ],
        [
          "Clinical action"
        ],
        [
          "thyronamine"
        ],
        [
          "Hypothermia, natural"
        ],
        [
          "Reduction - action"
        ],
        [
          "Negative"
        ],
        [
          "mechanism of action qualifier"
        ],
        [
          "Lower - spatial qualifier"
        ],
        [
          "Negative Chronotropy [PE]"
        ],
        [
          "Protoplasm"
        ],
        [
          "Djungarian Hamsters"
        ],
        [
          "Negative Inotropy [PE]"
        ],
        [
          "Rattus"
        ],
        [
          "chronotropic"
        ],
        [
          "Respiratory quotient"
        ],
        [
          "Central Minus"
        ],
        [
          "T prime"
        ],
        [
          "Extrinsic"
        ],
        [
          "Obese build"
        ],
        [
          "House mice"
        ],
        [
          "Depressed mood"
        ],
        [
          "Prompt"
        ],
        [
          "Initiate (source type)"
        ],
        [
          "Intraperitoneal"
        ],
        [
          "Mass, a measure of quantity of matter"
        ],
        [
          "Bed Status - Isolated"
        ],
        [
          "Various patch test substance"
        ],
        [
          "Opposite"
        ],
        [
          "Metabolite"
        ],
        [
          "Traumatic AND/OR non-traumatic injury"
        ],
        [
          "Similarity"
        ],
        [
          "Consequence of"
        ],
        [
          "Homeostasis"
        ],
        [
          "Direction"
        ],
        [
          "Etiology aspects"
        ],
        [
          "Low Cardiac Output"
        ],
        [
          "Cardiac Output"
        ],
        [
          "classical example"
        ],
        [
          "Ischemic"
        ],
        [
          "Initiation"
        ],
        [
          "derivatives"
        ],
        [
          "Preparation"
        ],
        [
          "Rapidly"
        ],
        [
          "Class"
        ],
        [
          "Injection of therapeutic agent"
        ],
        [
          "Resistant (qualifier value)"
        ],
        [
          "Unknown"
        ],
        [
          "Laboratory mice"
        ],
        [
          "Physiological Effects [PE]"
        ],
        [
          "Metabolism"
        ],
        [
          "Administration procedure"
        ],
        [
          "Heart"
        ],
        [
          "Lower body structure"
        ],
        [
          "Functional"
        ],
        [
          "Possible diagnosis"
        ],
        [
          "Reduced"
        ],
        [
          "Identified"
        ],
        [
          "Observed"
        ],
        [
          "Increased"
        ],
        [
          "3-iodothyronamine"
        ],
        [
          "Metabolic:-:Point in time:^Patient:-"
        ],
        [
          "Dose-dependent"
        ]
      ],
      "id": "534bb147aeec6fbd07000014",
      "ideal_answer": "Most recently, thyroid hormone derivatives were identified, the thyronamines which are decarboxylated thyroid hormones initiating physiological actions like lowering body temperature and heart rate, thereby acting in opposite direction to the classical thyroid hormones. A class of thyroid hormone metabolites has dramatic physiological effects on metabolism and heart rate by still-unknown mechanisms of action. Functional effects have been observed after administration of exogenous T(1)AM: in the isolated heart, a negative inotropic and chronotropic action was produced, and the resistance to ischemic injury was increased, possibly as a consequence of an action on intracellular calcium homeostasis. Intraperitoneal or central injection of 3-T(1)AM or T(0)AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass. In the mouse, thyronamines act rapidly in a nongenomic fashion to initiate hypothermia and decrease cardiac output and heart rate. Octopamine, beta-phenylethylamine, and tryptamine produced a dose-dependent negative inotropic effect as shown by reduced cardiac output (IC(50)\u003d109 microM, 159 microM, and 242 microM, respectively). In the same preparation a similar effect was produced by thyronamine and 3-iodothyronamine, with IC(50)\u003d94 microM and 27 microM, respectively. "
    },
    {
      "exact_answer": "yes",
      "id": "534bf050aeec6fbd07000015",
      "ideal_answer": "Intraperitoneal or central injection of 3-T(1)AM or T(0)AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass. "
    },
    {
      "exact_answer": [
        [
          "Proteins"
        ],
        [
          "Generic Role"
        ],
        [
          "Rheumatoid Arthritis"
        ],
        [
          "Preposition For"
        ],
        [
          "Pathogenesis"
        ],
        [
          "Neurodegenerative Disorders"
        ],
        [
          "Does play"
        ],
        [
          "MAL protein, human"
        ],
        [
          "Taxonomic"
        ],
        [
          "Multiple Sclerosis"
        ],
        [
          "Protein-arginine deiminase"
        ],
        [
          "Tobacco smoking behavior"
        ],
        [
          "Specific qualifier value"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Abnormal"
        ],
        [
          "suggestion"
        ],
        [
          "Appearance"
        ],
        [
          "Alzheimer\u0027s Disease"
        ],
        [
          "Prion Diseases"
        ],
        [
          "Associated with"
        ],
        [
          "Post-Translational Protein Processing"
        ],
        [
          "Involvement with"
        ],
        [
          "Pathologic"
        ],
        [
          "Autoantibodies"
        ],
        [
          "Peptides"
        ],
        [
          "Ms. - Title"
        ],
        [
          "Abnormal protein"
        ],
        [
          "RHEUMATOID ARTHRITIS (allelic variant)"
        ],
        [
          "Biological Markers"
        ],
        [
          "Including (qualifier)"
        ],
        [
          "Mouse Protein"
        ],
        [
          "ResponseLevel - modification"
        ],
        [
          "Disease Progression"
        ],
        [
          "Links List"
        ],
        [
          "Axial R"
        ],
        [
          "utilization qualifier"
        ],
        [
          "Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE Term"
        ],
        [
          "protein-arginine deiminase activity"
        ],
        [
          "Study"
        ],
        [
          "Alzheimer\u0027s Disease Pathway KEGG"
        ],
        [
          "VIM gene"
        ],
        [
          "PTMS gene"
        ],
        [
          "Prions"
        ],
        [
          "Scrapie"
        ],
        [
          "Cyclical"
        ],
        [
          "Nicotiana tabacum"
        ],
        [
          "Osteopenia"
        ],
        [
          "AUTOANTIBODY RESPONSE"
        ],
        [
          "Experimental Autoimmune Encephalomyelitis"
        ],
        [
          "Pad Mass"
        ],
        [
          "Once - dosing instruction fragment"
        ],
        [
          "Discover"
        ],
        [
          "Interested"
        ],
        [
          "Firstly"
        ],
        [
          "Postmortem period"
        ],
        [
          "Medical Device Break"
        ],
        [
          "Myelin"
        ],
        [
          "Generations"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "Epitopes"
        ],
        [
          "Biologic Development"
        ],
        [
          "Tissue Specimen Code"
        ],
        [
          "Geographic Locations"
        ],
        [
          "Geographic state"
        ],
        [
          "Advance"
        ],
        [
          "Reflecting"
        ],
        [
          "Autopsy"
        ],
        [
          "The science and art of healing"
        ],
        [
          "Relations"
        ],
        [
          "Aberrant"
        ],
        [
          "Malignant Neoplasms"
        ],
        [
          "Neurodegenerative Disorders Pathway"
        ],
        [
          "Triggered by"
        ],
        [
          "Reporting"
        ],
        [
          "Numerical value"
        ],
        [
          "Alteration"
        ],
        [
          "Nerve Degeneration"
        ],
        [
          "Adaptive"
        ],
        [
          "Decade"
        ],
        [
          "Autoimmune Diseases"
        ],
        [
          "pathogenic aspects"
        ],
        [
          "Etiology"
        ],
        [
          "Disease suspected"
        ],
        [
          "White matter"
        ],
        [
          "Entire bone (organ)"
        ],
        [
          "Percent normal"
        ],
        [
          "consider"
        ],
        [
          "Feature"
        ],
        [
          "Immune Tolerance"
        ],
        [
          "Severity of illness"
        ],
        [
          "Pathology processes"
        ],
        [
          "Possibly Related to Intervention"
        ],
        [
          "Example"
        ],
        [
          "Patient observation"
        ],
        [
          "Characterization"
        ],
        [
          "Numbers"
        ],
        [
          "Providing (action)"
        ],
        [
          "Relationships"
        ],
        [
          "nervous system disorder"
        ],
        [
          "Negative Finding"
        ]
      ],
      "id": "534df8c9aeec6fbd07000016",
      "ideal_answer": "These findings suggest that PAD2 and citrullinated proteins may play a key role in the brain pathology of prion diseases. aberrant citrullinated proteins could play a role in pathogenesis and have value as a marker for the postmortem classification of neurodegenerative diseases. It appears from our results that, tobacco smoking mostly play a role in progression of rheumatoid arthritis through tissue protein citrullination. Over the past decade, PADs and protein citrullination have been commonly implicated as abnormal pathological features in neurodegeneration and inflammatory responses associated with diseases such as multiple sclerosis, Alzheimer disease and rheumatoid arthritis. The aim of the present work was to study the effect of tobacco smoking on disease progression in rheumatoid arthritis patients and its relation to anti-cyclical citrullinated peptide (anti-CCP) antibodies. This study suggests that accumulated citrullinated proteins and abnormal activation of PAD2 may function in the pathogenesis of prion diseases and serve as potential therapeutic targets. We first discovered that abnormal myelin hypercitrullination, even in normal-appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. "
    },
    {
      "exact_answer": [
        [
          "Genetic Hotspot"
        ],
        [
          "DNA"
        ],
        [
          "Meiotic Recombination"
        ],
        [
          "1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione"
        ],
        [
          "Arabic numeral 65"
        ]
      ],
      "id": "534e364e288f4dae47000001",
      "ideal_answer": "In the fission yeast genome DSBs are located within 194 prominent peaks separated on average by 65-kbp intervals of DNA that are largely free of DSBs. meiotic recombination is initiated by double-strand DNA breaks (DSBs) which occur at relatively high frequencies in some genomic regions (hotspots) and relatively low frequencies in others (coldspots). Most meiotic recombination is positioned at hotspots, but knowledge of the mechanisms is nebulous. "
    },
    {
      "exact_answer": [
        [
          "invadopodium"
        ],
        [
          "CTTN protein, human"
        ],
        [
          "Phosphotransferases"
        ],
        [
          "MT1G wt Allele"
        ],
        [
          "cofilin"
        ]
      ],
      "id": "534eb34b288f4dae47000002",
      "ideal_answer": "Examination of cells at different time points as well as live-cell imaging revealed four distinct invadopodial stages: membrane cortactin aggregation at membranes adherent to matrix, MT1-MMP accumulation at the region of cortactin accumulation, matrix degradation at the invadopodia region, and subsequent cortactin dissociation from the area of continued MT1-MMP accumulation associated with foci of degraded matrix. In this report we show that the expression of activated versions of Src, Cdc42 and Rac1, or a kinase-dead but open form of the p21-activated kinase (PAK1), induces primary rat aorta VSMCs to form extracellular matrix-degrading actin-rich protrusions that are morphologically similar to the invadopodia formed by highly invasive tumor cells. Further investigation into the underlying molecular mechanisms revealed that the levels of key modulators of invadopodium maturation, including c-Src kinase, cortactin, and membrane type 1-matrix metalloproteinase (MT1-MMP) decreased when cells were treated with 6-shogaol or pterostilbene. Small interfering RNA (siRNA) inhibition established that organization of invadopodia structure requires cortactin, whereas protease inhibitor studies identified membrane type 1 matrix metalloproteinase (MT1-MMP) as the key invadopodial enzyme responsible for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231. "
    },
    {
      "exact_answer": [
        [
          "Rett Syndrome"
        ],
        [
          "RETT SYNDROME (allelic variant)"
        ],
        [
          "Methyl-CpG-Binding Protein 2"
        ],
        [
          "Genes"
        ],
        [
          "Mutation"
        ]
      ],
      "id": "534ebb59288f4dae47000004",
      "ideal_answer": "Rett syndrome (RTT) is an autism spectrum disorder caused by mutation in the gene encoding methyl CpG binding protein 2 (MECP2). Rett syndrome (RTT) results from loss-of-function mutations in the gene encoding the methyl-CpG-binding protein 2 (MeCP2) and is characterized by abnormal motor, respiratory and autonomic control, cognitive impairment, autistic-like behaviors and increased risk of seizures. MECP2 assists in the transcriptional silencing process via DNA methylation; we hypothesize that disruption of this gene alters the normal developmental expression of various other genes, some of which must account for the peculiar neurologic phenotype of RTT. The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction. Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder that manifests in females, typically after the first year of life. Severely arrhythmic breathing is a hallmark of Rett syndrome (RTT) and profoundly affects quality of life for patients and their families. "
    },
    {
      "exact_answer": [
        [
          "XIST gene"
        ],
        [
          "X (Inactive)-Specific Transcript"
        ],
        [
          "X CHROMOSOME INACTIVATION"
        ],
        [
          "silence"
        ],
        [
          "RNA, Long Untranslated"
        ]
      ],
      "id": "5353aedb288f4dae47000006",
      "ideal_answer": "X inactivation-specific transcript (XIST) is a long ncRNA that mediates X chromosome inactivation. IST, a long non-coding RNA, plays an important role in triggering X chromosome inactivation in eutherians. Xist (X inactive specific transcript) gene plays an essential role in X chromosome inactivation. deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation. efforts have been focused on the X inactive-specific transcript (Xist) locus, discovered to be the master regulator of X-inactivation. the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation. chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events. imprinted mouse Xist (X-inactive specific transcript) gene is involved in the initiation of X-chromosome inactivation. the X chromosome of paternal origin (Xp) is silenced during early embryogenesis owing to imprinted expression of the regulatory RNA, Xist (X-inactive specific transcript). "
    },
    {
      "exact_answer": [
        [
          "Transcript"
        ],
        [
          "Protein Isoforms"
        ],
        [
          "Base Sequence"
        ],
        [
          "RNA"
        ],
        [
          "Quantitation"
        ],
        [
          "Data"
        ],
        [
          "Reading (activity)"
        ],
        [
          "Scientific Equipment"
        ],
        [
          "Estimated"
        ],
        [
          "Abundance"
        ],
        [
          "Base - General Qualifier"
        ],
        [
          "Kit device"
        ],
        [
          "Computer software"
        ],
        [
          "RNA Splicing"
        ],
        [
          "user friendly software"
        ],
        [
          "Lasso"
        ],
        [
          "Normalize"
        ],
        [
          "Length of Trial"
        ],
        [
          "Genes"
        ],
        [
          "RNA Analysis"
        ],
        [
          "Accurate (qualifier)"
        ],
        [
          "Genome - anatomical entity"
        ],
        [
          "Estimation Method"
        ],
        [
          "Pair"
        ],
        [
          "MR vaccine"
        ],
        [
          "RNA, Messenger"
        ],
        [
          "Geographic Locations"
        ],
        [
          "Service Request Relationship - Simultaneous"
        ],
        [
          "Test Method"
        ],
        [
          "Discover"
        ],
        [
          "Transcriptome"
        ],
        [
          "Assignment - action"
        ],
        [
          "Exons"
        ],
        [
          "Grape Flavor"
        ],
        [
          "Model"
        ],
        [
          "Alignment"
        ],
        [
          "popularity"
        ],
        [
          "Minimum"
        ],
        [
          "Optical Image Reconstruction"
        ],
        [
          "Call (Instruction)"
        ],
        [
          "Mixed (qualifier value)"
        ],
        [
          "Unique"
        ],
        [
          "Identification (Psychology)"
        ],
        [
          "Analysis of substances"
        ],
        [
          "algorithm"
        ],
        [
          "Sequence Number"
        ],
        [
          "Approach"
        ],
        [
          "Levels (qualifier value)"
        ],
        [
          "Assembler"
        ],
        [
          "Negation"
        ],
        [
          "Miso"
        ],
        [
          "nuclear mRNA cis splicing, via spliceosome"
        ],
        [
          "Distributing"
        ],
        [
          "Upper case Roman letter O"
        ],
        [
          "Integer (number)"
        ],
        [
          "Entity Name Use - License"
        ],
        [
          "Forecast of outcome"
        ],
        [
          "Singular"
        ],
        [
          "Widening"
        ],
        [
          "Investigational"
        ],
        [
          "coverage - financial contract"
        ],
        [
          "Referring"
        ],
        [
          "Coordinate on an axis or a grid"
        ],
        [
          "Drug Packaging"
        ],
        [
          "Weighing patient"
        ],
        [
          "Inference"
        ],
        [
          "Package"
        ],
        [
          "Introduces"
        ],
        [
          "Genomics"
        ],
        [
          "Monte Carlo Method"
        ],
        [
          "Stop (qualifier value)"
        ],
        [
          "As Much as Desired"
        ],
        [
          "Science of Statistics"
        ],
        [
          "Fasting"
        ],
        [
          "Representation (action)"
        ],
        [
          "de novo"
        ],
        [
          "physiologic resolution"
        ],
        [
          "competition"
        ],
        [
          "Covered (qualifier value)"
        ],
        [
          "Reference Object"
        ],
        [
          "Not Applicable"
        ],
        [
          "Automated (qualifier value)"
        ],
        [
          "Requirement"
        ],
        [
          "Inclusion"
        ],
        [
          "Integration (data processing)"
        ],
        [
          "Simulation"
        ],
        [
          "Frequencies (time pattern)"
        ],
        [
          "Assembly (group of parts)"
        ],
        [
          "Availability of"
        ],
        [
          "Device Component System"
        ],
        [
          "Comprehensive"
        ],
        [
          "Event"
        ],
        [
          "Statistical Technique"
        ],
        [
          "Numbers"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Base"
        ],
        [
          "Effectiveness"
        ],
        [
          "Employed"
        ],
        [
          "Finding"
        ],
        [
          "Positive Finding"
        ]
      ],
      "id": "5354f289288f4dae47000008",
      "ideal_answer": "ORMAN ( O ptimal R esolution of M ultimapping A mbiguity of R N A-Seq Reads), which aims to compute the minimum number of potential transcript products for each gene and to assign each multimapping read to one of these transcripts based on the estimated distribution of the region covering the read. We present RSEM, an user-friendly software package for quantifying gene and isoform abundances from single-end or paired-end RNA-Seq data. We propose a novel algorithm (IsoformEx) that employs weighted non-negative least squares estimation method to estimate the expression levels of transcript isoforms. By resolving the linear system with LASSO, our approach can infer an accurate set of dominantly expressed transcripts while existing methods tend to assign positive expression to every candidate isoform. NEUMA (Normalization by Expected Uniquely Mappable Area), is based on effective length normalization using uniquely mappable areas of gene and mRNA isoform models. the Minimum Unique Length Tool (MULTo), a framework for efficient and comprehensive representation of mappability information, through identification of the shortest possible length required for each genomic coordinate to become unique in the genome and transcriptome. "
    },
    {
      "exact_answer": "yes",
      "id": "53552ed7f1005d6b58000001",
      "ideal_answer": "human Mowat-Wilson syndrome, we suggest that deletion of ZEB2, is responsible for most of the effects of the mutation. single-copy ZEB2 gene deletion at 2q22.3 consistent with Mowat-Wilson syndrome. syndrome is the result of heterozygous deletions or truncating mutations of the ZFHX1B (SIP1) gene. syndrome occurs as a result of heterozygous mutations or deletions in the zinc finger E-box-binding homeobox 2 gene, ZEB2, previously called ZFHX1B (SIP1). Mowat-Wilson syndrome is a genetic disease caused by heterozygous mutations or deletions of the zinc finger E-box-binding homeobox 2 (ZEB2) gene. Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene. ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects. owat-Wilson syndrome (MWS; OMIM #235730) is a genetic condition caused by heterozygous mutations or deletions of the ZEB2 gene. owat-Wilson syndrome (MWS) is an autosomal dominant developmental disorder with mental retardation and variable multiple congenital abnormalities due to mutations of the ZEB2 (ZFHX1B). owat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B). "
    },
    {
      "exact_answer": [
        [
          "Fascin"
        ],
        [
          "filopodium assembly"
        ],
        [
          "Actins"
        ],
        [
          "Filopodia"
        ],
        [
          "BAIAP2 gene"
        ],
        [
          "Lamellipodia"
        ],
        [
          "Fluorides"
        ],
        [
          "VASP protein, human"
        ],
        [
          "FSCN1 gene"
        ],
        [
          "actin bundling"
        ],
        [
          "Growth Cones"
        ],
        [
          "Actin bundling protein"
        ],
        [
          "Induce (action)"
        ],
        [
          "Involvement with"
        ],
        [
          "MTSS1 gene"
        ],
        [
          "cell motility"
        ],
        [
          "Proteins"
        ],
        [
          "Bone structure of rib"
        ],
        [
          "Mediator brand of benfluorex hydrochloride"
        ],
        [
          "Generic Role"
        ],
        [
          "Little\u0027s Disease"
        ],
        [
          "Singular"
        ],
        [
          "ruffle assembly"
        ],
        [
          "Staphylococcal Protein A"
        ],
        [
          "suggestion"
        ],
        [
          "actin filament bundle assembly"
        ],
        [
          "filamentous actin location"
        ],
        [
          "macrophage colony stimulating factor receptor activity"
        ],
        [
          "EPS8 gene"
        ],
        [
          "Tetradecanoylphorbol Acetate"
        ],
        [
          "protrusion"
        ],
        [
          "Type - attribute"
        ],
        [
          "In Vitro [Publication Type]"
        ],
        [
          "Experimental Result"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "Neoplasm Metastasis"
        ],
        [
          "Wild Type Unspecified - zebrafish"
        ],
        [
          "RNA, Small Interfering"
        ],
        [
          "Enhance (action)"
        ],
        [
          "Protein Overexpression"
        ],
        [
          "Cytoskeletal Filaments"
        ],
        [
          "Multiple malignancy"
        ],
        [
          "Tumor Cell Invasion"
        ],
        [
          "In Vivo"
        ],
        [
          "Morphogenesis"
        ],
        [
          "Formation"
        ],
        [
          "Epithelial"
        ],
        [
          "Organized"
        ],
        [
          "Neurogenesis"
        ],
        [
          "Increase"
        ],
        [
          "Epidermal Growth Factor Receptor Pathway Substrate 8"
        ],
        [
          "Green Fluorescent Proteins"
        ],
        [
          "Cells"
        ],
        [
          "FMN1 gene"
        ],
        [
          "Protein Kinase C Alpha"
        ],
        [
          "Parallel Lesion"
        ],
        [
          "Expression procedure"
        ],
        [
          "Increased"
        ],
        [
          "Antibodies"
        ],
        [
          "Family member"
        ],
        [
          "rho GTP-Binding Proteins"
        ],
        [
          "Regulation"
        ],
        [
          "Report (document)"
        ],
        [
          "Wiskott-Aldrich Syndrome Protein Family"
        ],
        [
          "Localized"
        ],
        [
          "Decreased"
        ],
        [
          "Neurons"
        ],
        [
          "Entire cell"
        ],
        [
          "Model"
        ],
        [
          "Dynamic"
        ],
        [
          "WASF2 gene"
        ],
        [
          "BAIAP2L1 gene"
        ],
        [
          "actin filament bundle"
        ],
        [
          "ENAH gene"
        ],
        [
          "PSTPIP2 gene"
        ],
        [
          "Superkingdom (taxonomic category)"
        ],
        [
          "microspike"
        ],
        [
          "Preposition For"
        ],
        [
          "negative regulation of filopodium assembly"
        ],
        [
          "filopodium tip"
        ],
        [
          "lamellipodium assembly"
        ],
        [
          "Negation"
        ],
        [
          "Support, device"
        ],
        [
          "VASP gene"
        ],
        [
          "Incised wound"
        ],
        [
          "Assortment"
        ],
        [
          "actin crosslink formation"
        ],
        [
          "Rattus"
        ],
        [
          "Barbiturate Drug Class Measurement"
        ],
        [
          "Adhesives"
        ],
        [
          "Microfilaments"
        ],
        [
          "Adapter Device Component"
        ],
        [
          "Purifying"
        ],
        [
          "SH3 Domain"
        ],
        [
          "RAC1 gene"
        ],
        [
          "Insertion of pack (procedure)"
        ],
        [
          "TP53 wt Allele"
        ],
        [
          "Neurites"
        ],
        [
          "Derivation"
        ],
        [
          "Invasiveness"
        ]
      ],
      "id": "5358e067f1005d6b5800000b",
      "ideal_answer": "F-ascin is an actin-bundling protein involved in filopodia assembly and cancer invasion and metastasis of multiple epithelial cancer types. Fascin is an actin-bundling protein involved in filopodia assembly and cancer invasion and metastasis of multiple epithelial cancer types. In this study, we investigated the role of fascin, a cytoskeleton actin-bundling protein involved in the formation of filopodia and cell migration, in prostate cancer progression. Actin-crosslinking proteins organize actin into highly dynamic and architecturally diverse subcellular scaffolds that orchestrate a variety of mechanical processes, including lamellipodial and filopodial protrusions in motile cells. In cellular models, fascin gene silencing using small interfering RNA in the androgen-independent prostate cancer cell line DU145 decreased cell motility and invasiveness while increasing cell adhesive properties. Overexpression of MAYP led to a reduction in total macrophage F-actin content but was associated with increased actin bundling. The IMD alone, derived from either IRSp53 or MIM, induced filopodia in HeLa cells and the formation of tightly packed parallel F-actin bundles in vitro. We report an unexpected direct association between fascin, an actin-bundling component of filopodia, microspikes and lamellipodial ribs, and protein kinase Calpha (PKCalpha), a regulator of focal adhesions. "
    },
    {
      "id": "535917f3c95abccd6f000001",
      "ideal_answer": "Agrobacterium tumefaciens causes crown gall disease in a wide range of plant species. robacterium tumefaciens is a plant pathogenic bacterium that causes neoplastic growths, called \u0027crown gall\u0027, via the transfer and integration of transferred DNA (T-DNA) from the bacterium into the plant genome. gall tumors develop after integration of the T-DNA of virulent Agrobacterium tumefaciens strains into the plant genome. grobacterium tumefaciens infects plants and induces the formation of tumors called \"crown galls\" by integrating the transferred-DNA (T-DNA) region of the Ti-plasmid into the plant nuclear genome. ransformation of plant cells with T-DNA of virulent agrobacteria is one of the most extreme triggers of developmental changes in higher plants. The neoplastic growth at the infection sites is caused by transferring, integrating, and expressing transfer DNA (T-DNA) from A. tumefaciens into plant cells. have identified T-DNA tagged Arabidopsis mutants that are resistant to transformation by Agrobacterium tumefaciens (rat mutants. grobacterium tumefaciens induces crown gall tumors on plants by transferring a nucleoprotein complex, the T-complex, from the bacterium to the plant cell. grobacterium tumefaciens causes crown gall disease by transferring and integrating bacterial DNA (T-DNA) into the plant genome. "
    },
    {
      "exact_answer": [
        [
          "Down Syndrome"
        ],
        [
          "Nuchal Translucency Screen"
        ],
        [
          "Antenatal screening procedures"
        ],
        [
          "No treatment required for"
        ],
        [
          "Always (frequency)"
        ]
      ],
      "id": "53592c1e9a4572de6f000002",
      "ideal_answer": "NT is physiological for a measurement \u003c 3 mm but the incidence of chromosomal abnormalities (essentially trisomies 21, 18 and 13) increases when NT \u003e or \u003d 3 mm. Combined prenatal screening was always positive for Down syndrome when NT thickness exceeded 4.0 mm. In women aged 35 to 37 years, combined prenatal screening was always positive when NT exceeded 2.8 mm, 3.0 mm, and 3.4 mm at 11, 12, and 13 weeks of gestation, respectively. "
    },
    {
      "exact_answer": [
        [
          "Coding"
        ],
        [
          "Annotated - DataType"
        ],
        [
          "Approximate"
        ],
        [
          "Proteins"
        ],
        [
          "Genes, vif"
        ]
      ],
      "id": "535d3c069a4572de6f000006",
      "ideal_answer": "Here, seven membrane protein topology prediction methods based on different underlying algorithms, such as hidden Markov models, neural networks and support vector machines, have been used for analysis of the protein sequences from the 21,416 annotated genes in the human genome. Clustering of these sequences using cross-species relationships suggests that millions of expressed sequences may correspond to only approximately 20,000 distinct protein-coding transcripts. he GENCODE 7 release contains 20,687 protein-coding and 9640 long noncoding RNA loci and has 33,977 coding transcripts not represented in UCSC genes and RefSeq. Current catalogs list a total of approximately 24,500 putative protein-coding genes. "
    },
    {
      "exact_answer": [
        [
          "hepcidin"
        ],
        [
          "Iron"
        ],
        [
          "Anemia"
        ],
        [
          "Immunoglobulins"
        ],
        [
          "Therapeutic procedure"
        ],
        [
          "Restricted"
        ],
        [
          "Blood group antibody A"
        ],
        [
          "Preposition For"
        ],
        [
          "HAMP gene"
        ],
        [
          "literary novel"
        ],
        [
          "Homo sapiens"
        ],
        [
          "Primary malignant neoplasm"
        ],
        [
          "Hemodialysis"
        ],
        [
          "Chronic Kidney Insufficiency"
        ],
        [
          "control substance"
        ],
        [
          "Improving (qualifier value)"
        ],
        [
          "Inflammation"
        ],
        [
          "strategy"
        ],
        [
          "Management procedure"
        ],
        [
          "Therapeutic"
        ]
      ],
      "id": "535d59349a4572de6f000009",
      "ideal_answer": "anti-hepcidin strategies for improving anemia control. anti-hepcidin therapies may improve anemia management in hemodialysis. Anti-hepcidin therapy for iron-restricted anemias. human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease. "
    },
    {
      "exact_answer": [
        [
          "Meta"
        ],
        [
          "Pathway Analysis"
        ],
        [
          "Network"
        ],
        [
          "Meta Analysis (statistical procedure)"
        ],
        [
          "Intervention regimes"
        ],
        [
          "Cessation of smoking"
        ],
        [
          "Smoking cessation assistance"
        ],
        [
          "Clinical Trials"
        ],
        [
          "Authorization Mode - Electronic"
        ],
        [
          "Computers"
        ],
        [
          "Pharmacotherapy"
        ],
        [
          "Cessation"
        ],
        [
          "Chronic Obstructive Airway Disease"
        ],
        [
          "overview"
        ],
        [
          "Acquired Immunodeficiency Syndrome"
        ],
        [
          "Associated with smoking"
        ],
        [
          "pharmacological"
        ],
        [
          "Review, Systematic"
        ],
        [
          "Cardiovascular event"
        ],
        [
          "Effectiveness"
        ],
        [
          "Cost Effectiveness"
        ],
        [
          "Including (qualifier)"
        ],
        [
          "Meta-Analysis (publications)"
        ]
      ],
      "id": "535d5bac7d100faa09000001",
      "ideal_answer": "Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. network meta-analysis on interventions for smoking cessation including over 100 trials. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. "
    },
    {
      "id": "535d613f7d100faa09000002",
      "ideal_answer": "With an overall high grade of evidence this review revealed an improvement of clinical results (ACR50, 28 joint disease activity score (DAS-28) remission and HAQ scores) with certolizumab pegol. SIE, most frequently pneumonia (IR 0.73/100 PY), were the most common serious AE, occurring more frequently in CZP compared to placebo-treated patients in RCT (IR 5.61/100 PY vs 1.35/100 PY, odds ratio (OR) 4.35, 95% CI 0.65 to 29.30). The cost-effectiveness of CZP relative to other bDMARDs is unclear because the economic modelling undertaken may have ignored relevant effectiveness data and potential differences between trial populations, and so may have included effectiveness results that were biased in favour of CZP. On the basis of results from the indirect comparison meta-analyses, the manufacturer suggested that CZP may be at least as effective as other \u0027biological\u0027 DMARD (bDMARD) comparators and, in a few ACR measures at 3 and 6 months, more effective. RESULTS: 4049 RA patients who received CZP were included in the safety pooling; total exposure 9277 PY, mean exposure 2.1 years (range 0.04-7.6). 58 deaths occurred in CZP-exposed patients (IR 0.63/100 PY) and 70 developed malignancies excluding non-melanoma skin cancer (IR 0.76/100 PY), including five lymphomas (IR 0.05/100 PY). "
    },
    {
      "exact_answer": "yes",
      "id": "535d75ab7d100faa09000004",
      "ideal_answer": "The results of this study have provided evidence of the hypoalgesic effects of TENS upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect. Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately. hypoalgesic effects of transcutaneous electrical nerve stimulation upon experimentally induced ischaemic pain. "
    },
    {
      "id": "535d78137d100faa09000005",
      "ideal_answer": "Acupuncture combined with auricular point sticking and pressing has reliable therapeutic effect for smoking cessation. Combined acupuncture with behavior counseling or with nicotine replacement therapy should be used in further smoking cessation trials to enhance the success rate of smoking cessation. Our results showed that auricular acupuncture did not have a better efficacy in smoking cessation compared to sham acupuncture. The combination of auricular acupressure and Internet-assisted smoking cessation program was more efficacious than auricular acupressure alone in terms of quit rate. Acupuncture and education, alone and in combination, significantly reduce smoking; however, combined they show a significantly greater effect, as seen in subjects with a greater pack-year history. A double blind, randomized, placebo-controlled clinical study was conducted to evaluate the efficacy of laser acupuncture treatment in adolescent smokers. With a one-year success rate of 41.1% ear acupuncture is a competitive alternative to orthodox medicine withdrawal methods. Combining ten studies showed auricular acupuncture at \u0027correct\u0027 points to be more effective than control interventions, odds ratio 2.24 (95% CI 1.61, 3.10),. Auricular (ear) acupressure has been purported to be beneficial in achieving smoking cessation in some studies, while in others has been deemed insignificant. "
    }
  ]
}